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ABSTRACT 
 
Background: It is estimated there are currently 2.6 million people living with a 
progressive neurological condition in England (Neurological Alliance, 2014).  
Neuropsychological assessment to detect associated cognitive changes are a 
primary aspect of care, yet little is known about how neuropsychological 
assessment is experienced. 
 
Aims: This study captures the experience of undergoing a neuropsychological 
assessment from the viewpoint of clients with neurodegenerative conditions. 
 
Methodology: Semi-structured interviews were conducted with eight people with 
neurodegenerative conditions, who had recently undergone a neuropsychological 
assessment.  The transcripts were analysed using Interpretative 
Phenomenological Analysis (IPA). 
 
Results: Four interrelated superordinate themes emerged from analysis: 
expectations of assessment, relationship with clinician, experience during testing 
and outcome of assessment.  Overall, the experience of neuropsychological 
assessment was characterised as emotional and intense experience, yet most 
talked about the process as a positive experience.  Participants hoped the 
assessment would objectively measure suspected or ‘hidden’ cognitive deficits, to 
increase understanding and help them cope with potential impairments.  
Participants reported the relationship with the assessing clinician was vital in 
determining their experience and helping them to withstand the emotional 
stresses of testing.  Participants described diverse experiences during testing, 
from enjoying a sense of retained ability, to feelings of frustration, stress and 
disappointment at perceived ‘failure’.  Various coping strategies were utilised to 
cope with the evoked emotions.  The assessment environment was highlighted 
as important, with distractors felt to negatively impact performance.  There was a 
sense the assessment provided objective ‘proof’ of the presence or absence of 
cognitive deficits, with accessible and prompt written feedback empowering 
participants to cope, adjust to difficulties and increasing relative’s awareness.  
Participants described mixed responses to feedback, from a therapeutic sense of 
 iii 
 
relief, to feeling forced to confront the objective description of the impact of their 
condition.  Despite participants reporting some negative aspects to testing, most 
emerged with a sense of having benefited from the experience. 
 
Implications and Conclusions: The findings of the study are considered in light 
of existing research, with consideration given to future research opportunities.  
The implications for clinical practice and training are discussed, including 
recommendations of pre-assessment meetings to prepare clients for the process 
(including the emotional aspects), and testing to be conducted by a familiar 
clinician, with whom the client has built rapport, and who can provide 
reassurance to offset the inherent uncertainty over performance.  Providing an 
optimal environment, and ensuring feedback is timely, comprehensible and 
meaningful were also found to be of importance. 
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1. INTRODUCTION 
 
 
1.1. Overview 
 
This chapter will provide context, by firstly examining neurodegenerative 
conditions, including their classification, incidence, prevalence, aetiology, 
prognosis and impact.  Following this, I will describe the process of 
neuropsychological assessment, before considering its application to clients with 
neurodegenerative conditions.  The existing literature on the experience of 
neuropsychological assessment will be evaluated, focussing on the few existing 
studies including people with neurodegenerative conditions.  I will consider the 
inclusion of people with neurodegenerative conditions in research, providing a 
rationale for the study’s overall aims. 
 
In keeping with the epistemological position, I will write in first person where 
required, to aid transparency and reflexivity as a qualitative researcher (Webb, 
1992).  The term participant, patient and client will be used interchangeably 
throughout.  In addition, the terms ‘neuropsychological’, ‘cognitive’ and 
‘psychometric’ assessment are often confused in both theory and practice, with 
psychometrics relating to the psychological measurement of various traits, and 
cognitive assessments used as a broad term for testing performed by various 
professions, particularly in educational settings (Boake & Block, 2015).  For 
clarity’s sake, I will use the term neuropsychological assessment to refer to the 
comprehensive standardised testing performed by clinical psychologists. 
 
1.2. Neurodegenerative Conditions 
 
Broadly speaking, ‘neurodegenerative conditions’ is an umbrella term for 
diseases characterised by progressive and irreversible degeneration and/or 
death of neurones in the central nervous system (CNS; comprising of the brain 
and spinal cord), resulting in incurable and debilitating conditions.  There is 
estimated to be several hundred different neurodegenerative conditions, yet 
attention has focused on the most common or publicised, classically Alzheimer’s 
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disease, Parkinson’s disease (PD), multiple sclerosis (MS), Huntingdon’s disease 
(HD), motor neurone disease (MND) and multiple system atrophy (MSA) (Joint 
Programme Neurodegenerative Disease Research, 2017; Przedborski, Vila & 
Jackson-Lewis, 2003).  Neuroanatomically, neurodegenerative conditions include 
the dementias, however in practice, a distinction is made between the dementias, 
which typically affect older adults versus neurodegenerative conditions that 
typically affect younger people and involve a significant sensory-motor 
component.  Throughout this study, I will use the term neurodegenerative 
conditions to refer to the latter.  The justification being that neuropsychological 
assessment plays a significant role in the diagnosis of dementia (and with 
considerable associated stigma), the experience of people with possible 
dementia, may be very different to that of people with other neurodegenerative 
conditions.   
 
1.2.1. Classification 
The prominent types of neurodegenerative condition are outlined below, and are 
typically categorised using a combination of a clinicopathological approach (i.e. 
based directly on observable symptoms), and a topographical approach (i.e. 
based on the distribution of lesions).  Unfortunately this can prove challenging, as 
the underlying pathological markers of disease, do not always correspond to 
observed symptoms.  For instance, the brain of individuals diagnosed with one 
neurodegenerative condition, could also exhibit pathological characteristics for 
another (Greater Boston Physicians for Social Responsibility [GBPSR] & Science 
and Environmental Health Network [SEHN], 2008).  Hence, the clinical and 
pathological characteristics exhibited often overlap, not discretely matching one 
condition, and the same neurodegenerative process can affect different brain 
regions, or several simultaneously, giving rise to varying symptoms, resulting in 
dramatically different clinical pictures (Przedborski et al., 2003).  Therefore, 
although pathological analysis may be regarded as the gold standard in many 
diseases, it cannot meaningfully be applied to neurodegenerative conditions 
(Gómez-Rio, Caballero, Górriz Sáez & Minguez-Castellanos, 2016), meaning 
diagnosis often relies on subjective clinical judgement. 
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Whilst it is appealing to believe that each neurodegenerative condition has 
distinct causes, characteristics and pathological features, the assumption of “one 
disease, one pathology” (GBPSR & SEHN, 2008, p.60) has been largely 
disregarded.  Nevertheless, it continues to underpin the current diagnostic 
standards, resulting in a system that is inadequate in the vast majority of cases, 
and making differential diagnosis challenging, especially in early phases or 
atypical variants (Gómez-Rio et al., 2016).  Further difficulties are encountered as 
symptoms are often mild and nonspecific initially, before growing progressively 
worse, hence there is uncertainty as to when symptoms warrant a disease label 
(GBPSR & SEHN, 2008).   
 
Moreover, there is a lack of clarity around distinguishing neurodegenerative 
processes from ‘normal’ aging.  For instance, amyloid plaques have been found 
to be the single greatest predictor of cognitive impairment, however plaques are 
also commonly found in seemingly healthy people (GBPSR & SEHN, 2008).  It is 
possible these plaques do not occur ‘normally’, but represent a pre-symptomatic 
stage of disease which would’ve developed had the person lived long enough 
(Przedborski et al., 2003).  Przedborski et al., (2003) concluded that although 
mild cognitive changes are common in elderly individuals, this does not make 
them ‘normal’, with studies showing very few plaques in individuals with no 
cognitive decline (Morrison & Hof, 1997), suggesting aging and 
neurodegeneration represent distinct entities.  
 
Reliance on the current classification system has hampered early detection and 
hindered progress in identifying the causes and mechanisms underlying 
conditions.  This is crucial for discovering and monitoring the efficacy of new 
treatments, when conditions may be most amenable to treatment (Noble & Burns, 
2010).  Furthermore, it has contributed to misdiagnosis, with up to 20% of 
patients diagnosed with PD found to have a different disorder at autopsy (Stacy & 
Jankovic, 1992).  Without undermining the usefulness of the current classification 
system in providing a shared clinical language and peer support to those 
diagnosed, the poor correlation between pathological markers and clinical 
symptoms has prompted exploration of alternatives.  A recent report suggested 
that rather than viewing neurodegenerative conditions as distinct entities, they 
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could be more meaningfully viewed on a continuum of age-associated cognitive 
impairment (GBPSR & SEHN, 2008).  Alternatively, Przedborski et al. (2003) 
suggested a classification system based on molecular characteristics (e.g. 
disease of cerebral cortex, basal ganglia or cerebellum etc.), which can be further 
classified based on clinical features (e.g. dementing versus non-dementing), 
which they hoped would identify common mechanisms underlying the disease 
and open new treatment avenues. 
 
1.2.1.1. Parkinson’s disease: With the highest prevalence rate of any 
neurodegenerative condition, PD is the most common cause of a set of motor 
symptoms known as Parkinsonisms, which include tremor (usually beginning in 
the hands), bradykinesia (slowness of movement) and muscle rigidity (stiffness) 
(DeMaagd & Philip, 2015; NHS Choices, 2016b), as well as numerous non-motor 
symptoms suggested to occur during a preclinical phase (Schrag, Horsfall, 
Walters, Noyce & Petersen, 2015).  Onset is typically between 50-60 years 
(although it can occur in young adults), with men at 1.5 times greater risk 
(Wooten, Currie, Bovbjerg, Lee & Patrie, 2004).  PD predominantly affects 
dopamine-producing neurones in a brain area called the substantia nigra, 
resulting in reduced dopamine levels.  As dopamine acts as a messenger to help 
control and co-ordinate movement, motor symptoms result, appearing after 80% 
of nerve cells have been lost (NHS Choices, 2016b). 
 
1.2.1.2. Multiple sclerosis: MS is an autoimmune condition, in which the body’s 
immune system mistakenly launches an attack directed against the myelin 
sheaths insulating nerves in the CNS (NHS Choices, 2016a).  The resulting 
inflammation and damage disrupts and distorts nerve impulses traveling to the 
rest of the body, leaving behind scarring (sclerosis).  Women are three times 
more likely to be diagnosed, typically in their 20s and 30s (NHS Choices, 2016a).  
With lesions disseminated in time and space, the course is highly variable and 
unpredictable; for some, symptoms develop and steadily worsen, whilst others 
experience periods of relapse and remission (Cosh & Carslaw, 2014; Goldenberg 
2012). 
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1.2.1.3. Huntingdon’s disease: HD is caused by a dominantly inherited faulty 
gene which results in damage to neurones.  The offspring of carriers of the faulty 
gene have a 50% chance of inheriting the disease (Myers, 2004).  The onset of 
symptoms is typically between 30-50 years and is usually fatal 15-20 years after 
symptoms start (NHS Choices, 2018).   
 
1.2.1.4. Motor neurone disease: MND, as the name suggests, affects motor 
neurones, resulting in progressive weakness of limbs, bulbar and respiratory 
muscles, ultimately proving fatal, usually within three to five years (Shaw & 
Wood-Allum, 2010).  There are four main types, with amyotrophic lateral sclerosis 
the most common (MNDA, 2017). 
 
1.2.1.5. Multiple systems atrophy: MSA is caused by degeneration of nerve cells 
in several areas of the brain over time and is a fatal and rapidly progressing 
disease.  Recent studies confirmed a key role of alpha-synuclein aggregation in 
the disease’s development, which is thought to be responsible for the progressive 
and widespread cell loss (Wenning, Stefanova, Jellinger, Poewe & 
Schlossmacher, 2008). 
 
1.2.2. Incidences and Prevalence 
The Neurological Alliance (2014) estimated there are 2.6 million people living with 
a progressive neurological condition in England, of which 106,680 people are 
suffering from PD, 84,000 from MS, 6,580 from HD, 3,750 from MND and 2,520 
from MSA.  The most consistent risk factor for developing a neurodegenerative 
condition is increasing age (Tanner, 1992), although they vary significantly with 
each condition.  It is difficult to assess incidence of neurodegenerative conditions, 
as many are not accurately diagnosed until the disease process reaches 
advanced stages.  Even symptom onset, does not equate with onset of disease, 
which could have been occurring for several years before “residual neurones… 
fall below the number required to maintain normal functioning” (Przedborski et al., 
2003, p.6-7).  Unfortunately, lack of pre-symptomatic markers restricts the ability 
to determine ‘true’ onset, resulting in a prevalence diagnosis gap, hence actual 
numbers are almost certainly higher (McGovern Institute for Brain Research at 
Massachusetts Institute of Technology, 2014; Przedborski et al., 2003).  
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Furthermore, as neurodegenerative conditions primarily strike in mid to late life, 
and with continued population growth and an aging population, their prevalence 
is expected to soar (Bokde et al., 2011).  For instance, the prevalence of PD is 
estimated to double by 2065 (Parkinson’s UK, 2018).  With the predicted rise in 
prevalence, the number of people living with long term disability will increase, 
resulting in substantial societal cost in the form of healthcare, lost productivity 
and carer burden (Findley, 2007).  In the UK, the annual economic burden is 
estimated to be between £449 million to £3.3 billion for PD (Findley, 2007) and 
£3.3 to £4.2 billion for MS (MS Society, n.d.). 
 
1.2.3. Aetiology 
With few exceptions, the causes and mechanisms underlying the chronic 
progression of neurodegenerative conditions remains unknown (Gao & Hong, 
2008).  Even in cases where aetiology has been identified (such as the faulty 
gene responsible for HD), the mechanisms which provoke the disease onset are 
speculative, at best (Przedborski et al., 2003).  Within the field, there is debate 
regarding the relative contributions of genetic versus environmental factors in the 
initiation of disease.  Some conditions have an unmistakeably familial 
occurrence, suggesting a dominant inherited (e.g. HD), recessive inherited or 
sex-linked disorder.  Even some conditions which are essentially sporadic, show 
a small genetic element (e.g. PD or MND where 10% are familial) (Przedborski et 
al., 2003).  For cases that are truly sporadic, many occur within geographic or 
temporal clusters, supporting the suggestion that toxic environmental factors are 
the likely cause.  For instance, lack of sunlight/vitamin D and viral infections have 
been implicated in the occurrence of MS (NHS Choices, 2016a), and various 
toxic compounds and pesticides have been suggested to produce parkinsonian 
syndrome or elevate risk of PD, respectively (Brouwer et al., 2017; Kurtland, 
1988; Przedborski & Vila, 2001).  Yet, evidence linking environmental factors to 
PD remains inconclusive, with studies failing to show a definitive association 
(Tanner, 1989).  Collectively, the findings suggest sporadic cases probably result 
from a combination of genetic and environmental factors, with environmental 
factors potentially influencing gene expression (Przedborski et al., 2003). 
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1.2.4. Impact 
The consequences of neurodegenerative conditions vary significantly between 
individuals, depending on the type, severity and region of CNS affected.  
However, they are commonly associated with deterioration across several 
domains, including physical (motor symptoms), cognitive (memory loss), 
emotional (apathy, depression and anxiety) and behavioural (disinhibition) 
symptoms (Levenson, Sturm & Haase, 2014).  Physical impairments typically 
include movement, balance and coordination problems, fatigue, weakness, 
sensory loss, difficulties with swallowing, speech and vision, sexual problems and 
problems with functions controlled by the autonomic nervous system (e.g. 
breathing, blood pressure or bladder and bowel control) (Batista & Pereira, 2016).  
Cognitive impairments include difficulties with executive function (planning, 
organising and problem solving), learning and memory, language, visuospatial 
function, attention, concentration and information processing speed.  Cognitive 
deficits occur in approximately 30-50% of patients (Broeders, Velseboer, De Bie 
& Speelman, 2016; Brown et al., 2010; Duff et al., 2010; Medical Advisory Board 
of the National Multiple Sclerosis Society, USA, 2008; Motor Neurone Disease 
Association [MNDA], 2018), with 10-15% developing an impairment severe 
enough to be considered early-onset dementia (Longley, 2007; MNDA, 2018).  It 
has been suggested cognitive and behavioural changes are the most debilitating 
aspect, both for family’s adjustment and the person’s long-term functional 
outcome (Longley, Tate & Brown, 2012; Paulsen, 2011). 
 
Whilst important to capture cognitive deficits, this does not capture the dramatic 
emotional and social impact, which extends far beyond obvious disease 
symptoms (Levenson et al., 2014; Welsh, 2001).  The domains affected range 
from sleep (Schrempf, Brandt, Storch & Reichmann, 2014), mood (Baquero & 
Martin, 2015), personal self-care (Rao et al., 1991), social and leisure activities 
(Rao et al., 1991), interpersonal relationships and martial satisfaction (Chipchase 
& Lincoln, 2001; Schrag, Hovris, Morley, Quinn & Jahanshahi, 2003), 
employment (Rao et al., 1991) and driving (Schultheis, Garay, Millis & DeLuca, 
2002) and can significantly impact on quality of life (Batista & Pereira, 2016).  The 
wide-reaching affects, often impair people’s ability to maintain essential life roles, 
giving rise to negative self-perceptions, lower emotional wellbeing and social 
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stigma which impacts not only individuals, but also families and societies (Batista 
& Pereira, 2016). 
 
1.2.5. Prognosis and Treatment 
Most neurodegenerative conditions progress slowly over the course of several 
years, ultimately limiting life expectancy and affecting a person’s ability to function 
to the extent that they may become dependent on care.  It is likely the rate of 
neuronal death remains relatively stable throughout the course of the disease, 
with sudden symptomatic deteriorations explained when neuronal levels drop 
below a functional threshold (Przedborski et al., 2003).  In some instances, death 
can result directly from the neurodegenerative condition impairing the ability of 
vital respiratory or cardiac functions, such as in MND.  However, for a large 
majority, death is not attributed directly to the disease, but due to occurrence of 
secondary health conditions that result from motor and cognitive impairments, 
including fatal accidents and falling.  There is no evidence neurodegenerative 
conditions increase the risk of developing common comorbidities, such as stroke, 
cancer or cardiovascular disease, which are the leading causes of death in 
developed countries (Przedborski et al., 2003). 
 
Although the past few decades have seen considerable advances in 
understanding neurodegenerative conditions, significant challenges remain in 
their classification and treatment (Noble & Burns, 2010; Young, 2009).  There are 
currently no cures for neurodegenerative conditions, but there are numerous 
disease modifying or symptomatic treatments, attempting to maintain quality of 
life.  Unfortunately, prolonged use of recommended medications can cause 
debilitating side effects, and lack of knowledge regarding the causes of disease 
has hampered attempts at preventative approaches (Przedborski et al., 2003).  
Yet, the search for effective treatment continues with increasing urgency, and 
hope remains of a cure, amongst discoveries of innovative drug treatments and 
gene therapy trials. 
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1.3. Neuropsychological Assessment 
 
Neuropsychological assessment is the “normatively informed application of 
performance-based assessments of various cognitive skills” (Harvey, 2012, p.91).  
Typically, tests are administered in a battery approach, taking two to six hours, to 
assess a range of cognitive domains such as attention, processing speed, 
memory and learning, problem solving, visuo-spatial, language and executive 
functions.  Neuropsychological assessments are commonly used to detect, 
assess and diagnose cognitive impairments resulting from neurological illness or 
injury, to help formulate treatment plans, aid clinical decision-making and monitor 
change (Lezak, Howieson, Bigler & Tranel, 2012).  The specific tests selected 
generally depend on the referrer’s request, clinician’s preference and the issue 
pertinent to the client, with the underlying aim being to understand what brain 
regions and networks are involved in specific behaviours.  Neuropsychological 
testing makes up a core component of clinical neuropsychologists’ work, and they 
are usually administered alongside observations of behaviour, self-report 
questionnaires and detailed clinical interviews to review pre-morbid functioning, 
medical background, and behavioural and emotional functioning. 
 
The British Psychological Society’s (BPS; 2003) professional guidelines make 
numerous recommendations aimed at enhancing professional standards adopted 
by neuropsychologists.  The guidelines cover the use of neuropsychological tests 
in clinical practice, medico-legal practice and research, and state only those with 
appropriate training and experience, familiar with associated literature and 
relevant manuals, should administer, score and interpret the tests.  Additionally, 
all clinical neuropsychologists should take care to gain consent of the client prior 
to any discussion with family, carers and other agencies, and should take into 
consideration the client’s context, including age, diagnosis, ethnicity and social 
and cultural variables.  As Lezak et al. (2012) notes, clinicians inevitably bring 
their own assumptions and biases to the process, hence they have an ethical 
responsibility to continually update their knowledge.   
 
The process of neuropsychological assessment usually begins with the client 
being given verbal or written preparatory information, either in a separate session 
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or immediately beforehand (Schoenberg & Scott, 2011).  Lezak et al. (2012) 
recommends this include straightforward and understandable explanations 
regarding the purpose and nature of the testing, the possible outcomes, 
confidentiality and a chance to explore the client’s engagement with testing.  
Inadequate preparation may lead clients to misinterpret standardised assessment 
procedure, for instance clients may believe they are not being permitted access 
to necessary information for successful testing (Foran, Millar & Dorstyn, 2016).  
Clients will often bring a person of their choice during the clinical interview and 
feedback session, but best practice is for them to complete the testing session 
alone.  
 
To support clients to perform their best, neuropsychological testing should be 
undertaken in optimal conditions: in a quiet, well-lit and ventilated room at a 
comfortable temperature.  Unlike other medical assessments (e.g. a MRI scan), 
neuropsychological assessments have a uniquely relational element, meaning a 
thoughtful examiner can improve the situation.  A competent clinician, should be 
mindful of anxiety, and prepared to intervene, putting people at ease with 
continual encouragement or random praise, and perhaps asking a simple 
question to maintain therapeutic rapport (Lezak et al., 2012).  By creating a 
comfortable, patient-focused environment, clients will be inclined to provide a 
deeper level of information and may be more receptive to explanations and 
recommendations, enabling mutual understanding.  It follows that client’s 
satisfaction with testing increases if they feel confidence and trust in clinicians, 
and if there is ongoing dialogue and exchange of information (Roberts, Stiller & 
Dichiera, 2012).  As highlighted, it is vitally important to pay attention and value 
subjective experience if we are to improve practice, yet it requires the skill of 
clinicians to carefully balance obtaining a comfortable environment whilst 
maintaining standardisation procedures (Kaufman & Lichtenberger, 1999). 
 
Most neuropsychological tests are norm-referenced, meaning an individual’s 
performance can be compared to that of his or her peers of the same age or 
educational level.  Therefore, it is of vital importance that neuropsychological 
tests are administered in a standardised way to ensure reliability and validity of 
measures, and precision of subsequent interpretations.  It is for this reason, the 
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dialogue between clinician and patient is highly structured, with clinicians 
encouraged to adhere to prescribed administration instructions used during test 
standardisation.  This often includes specific instructions on wording, detailed 
directions regarding the presentation of test material and being strongly 
discouraged from revealing any feedback during the testing session.   
 
Whilst this enables clinicians to discover the individual characteristics of each 
person’s response, it might create a ‘coldness’ and affords little flexibility in 
offering emotional support to the client (Lezak et al., 2012).  This can be anxiety 
provoking for the client, as given limited feedback, they may assume they are 
failing or displeasing the examiner, increasing anxiety and potentially 
compromising test performance (Bennett-Levy et al., 1994).  In addition to 
anxiety, several other factors can affect test performance, including fatigue, 
distractions, awareness of poor performance and motivational variations.  For 
instance, as the process is demanding and time consuming, those who fatigue 
easily may notice concentration diminishes and performance deteriorates 
(Paterson & Scott-Findlay, 2002).  Awareness of these increased ‘failures’ can 
affect mood, not only interfering with performance, but potentially contributing to 
longer-term emotional consequences, with the stigma of cognitive impairment 
threatening self-esteem and leading to negative self-identity (Krohne et al., 2011). 
 
It is also necessary to consider the limitations of neuropsychological tests.  With 
the majority developed and norm-referenced in Western, English speaking 
cultures, the construct validity (the degree to which a test measures what it 
claims) is likely to vary according to ethnic group (Brickman, Cabo & Manly, 
2006).  Moreover, neuropsychological assessment may have a reduced value 
where physical disability is present, including difficulties with vision, hearing, 
speech and writing, which require a bespoke approach (Bokde et al., 2011).  In 
addition, although tests attempt to use large samples for standardisation, the 
reality of normative data means scores falling in the extreme ranges (i.e. superior 
or impaired ranges) are compared to relatively little data, sometimes based on 
only a handful on individuals.  Ceiling and floor effects can result in deceptive 
scores, especially for individuals with high or low pre-morbid functioning, where 
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scores may lack sensitivity or falsely exaggerate impairments, respectively 
(Bokde et al., 2011).   
 
Whilst neuropsychological assessment may attempt to measure the underlying 
constructs of cognitive domains, there has been a shift towards focussing on 
what extent performance on tests correspond with real-life everyday cognitive 
function (ecological validity), rather than diagnosis.  Unfortunately, the tests 
themselves have not been updated to reflect this, hence achieve only moderate 
levels of ecological validity (Chaytor & Schmitter-Edgecombe, 2003), not 
capturing the cognitive complexity required for many routine activities (Lezak, 
1987).  Furthermore, a purely test-centred approach, perhaps fuelled by a sense 
of professional ‘ownership’ of testing, risks overlooking social context, for 
instance the client’s living environment, meaning any recommendations based 
solely on testing should remain tentative (Gass & Brown, 1992).  With 
neuropsychological assessment typically presented as a benevolent process, 
often minimised as ‘pen and paper puzzles’ to relieve anxiety, it is important to 
advocate for a balanced description to ensure truly informed consent and 
relinquish some of the ‘power’ held by clinicians (Genevay, 1997). 
 
The feedback session is a crucial part of the process, arguably forming an 
intervention in its own right.  It is recommended that client-friendly feedback be 
provided in both verbal and written form (including a report to the client, GP and 
referrer), as well as providing space to discuss concerns and offering follow up 
support (Smith, Wiggins & Gorske, 2007; Westervelt, Brown, Tremont, Javorsky 
& Stern, 2007).  Gass and Brown (1992) recommend six steps when providing 
feedback; reviewing the purpose, defining the tests, explaining test results, 
describing strength and weaknesses, addressing diagnostic and prognostic 
issues, and making recommendations.  Unfortunately, numerous patients 
comment they never received feedback about their performance, with some 
receiving second-hand feedback from referrers, which can understandably 
increase patient’s distress (Bennett-Levy, Klein-Boonschate, Batchelor, McCarter 
& Walton, 1994; Gass & Brown, 1992).  There may be a reluctance to share 
feedback if it is ambiguous or undesirable (Krohne, Slettebø & Bergland, 2011; 
Smith et al., 2007), moreover it may prove difficult for patients who lack cognitive 
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capacity or educational background to process the feedback in a meaningful way 
(Henderson, Caplan & Daniel, 2004); yet one could argue it is unethical to 
withhold. 
 
1.3.1. Neuropsychological Assessment in Neurodegenerative Conditions 
Although physical impairments are the most obvious deficit, it is cognitive, 
behavioural and emotional deficits, with their high prevalence and persistence, 
which have a significant impact on functioning and predict long-term outcome 
(Paulsen, 2011).  With neuropsychological assessment evaluating cognitive 
function and considering behavioural and emotional difficulties, it is valuable for 
people with neurodegenerative conditions and their families in several ways.  
Firstly, as neurodegenerative diseases have specific and sometimes distinct 
profiles of cognitive change depending on the pattern of cerebral deterioration, 
assessment can be of value in diagnosing the type of disease, differentiating it 
from other organic (i.e. dementia) or nonorganic causes (i.e. affective disorders) 
(Bokde et al., 2011).  Secondly, repeated testing can detect subtle cognitive 
deficits (American Academy of Neurology, 1996), and assess rate of change 
overtime, with deterioration over that expected from aging suggestive of a 
degenerative process (Bokde et al., 2011). Thirdly, assessment can provide 
information on the daily functional consequences of the disease, provide targets 
for support, hence informing treatment.  Finally, it can assist in making practical 
decisions regarding a person’s ability to function independently and guide 
recommendations on capacity issues (Bokde et al., 2011).   
 
Whilst test administration is highly standardised, the specific referral pathways, 
timings of assessments and process protocols vary case by case depending on 
clinical need and service context.  For instance, the timing of administration of an 
assessment is likely to reflect its varied functions throughout the disease course, 
with early testing assisting in diagnosis or aiming to achieve a baseline against 
which future assessments can be compared.  The inconsistencies in referral 
pathways are important to consider, as the way in which a client learns about 
their referral (and whether they agree it may be beneficial) can evoke diverse 
responses in cooperation, anxiety and trust, affecting test performance (Hartfield, 
Cason & Cason, 1982).   
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Despite recent calls for a more harmonious approach (Costa et al., 2017), debate 
continues over how neuropsychological assessment is best utilised with 
neurodegenerative conditions.  Many clinicians favour a flexible battery, arguing it 
appropriate (and economically beneficial) to solely administer tests that relate to 
the patient’s specific complaints, yet others argue this simply confirms the 
existence of readily observed symptoms (Reitan & Wolfson, 2001).  Reitan and 
Boll (1971) recommend every patient should benefit from a comprehensive 
battery, utilising both specific and general tests, covering a full range of 
neuropsychological functions, to gain a holistic understanding of intra-individual 
differences in performance.  With motor symptoms alleviated relatively simply in 
PD, it is critical to ensure cognitive deficits do not lag behind, creating a ‘weak 
link’, preventing functional impairment (Reitan & Wolfson, 2001).  Similarly, with 
studies in MS demonstrating many cognitive deficits are unsuspected or 
unconfirmed (Longley, Tate & Brown, 2012; Peyser, Edwards, Poser & Filskov, 
1980), comprehensive neuropsychological assessment can be crucial to detect, 
objectively confirm and monitor cognitive deficits. 
 
Certainly, clinicians have ethical responsibilities, including to avoid harm to 
patients, to be competent in test selection, administration and interpretation, to 
ensure appropriate documentation of results and to avoid release of raw data 
(Binder & Thompson, 1995).  More specifically, where neurodegenerative 
conditions are concerned, the number of controversies regarding classification, 
aetiology and assessment can result in inconsistencies and variation across 
clinicians, which could also be considered an ethical issue (Wong, 2006).  For 
instance, ethical debates continue regarding appropriate test selection, including 
whether to offer a flexible or comprehensive battery, whether assessment should 
be functionally or diagnostically driven, at what stage of disease and how often 
assessment should be offered, and whether it is ever appropriate not to offer 
(especially if there is reason to believe the outcome would be unhelpful).  With 
such variations certain to impact patient’s experience, the American 
Psychological Association’s (2002) ethical standards encourage clinicians to 
undertake necessary preparation when working with a new client group, by 
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becoming familiar with and carefully considering the entire spectrum of existing 
literature, empirical findings and associated controversies. 
 
1.4. Literature Search 
 
I conducted a literature search using psychological and medical databases; 
PsychINFO, Academic Search Complete, CINAHL Plus via EBSCO and 
ScienceDirect, Cochrane Library, Scopus, and MEDLINE.  The following search 
terms were used in various combinations, using the Boolean operators ‘AND’ and 
‘OR’; 
 Neuropsychological assessment 
 Cognitive assessment 
 Client satisfaction 
 Satisfaction 
 Experience 
 Neurodegenerative diseases 
 
The search strategy also included reviewing reference lists and citations of 
relevant articles and searching widely using internet browsers (Google Scholar) 
and open source repositories (Research Gate, EThOS) to find additional relevant 
articles, conference papers and unpublished work.  Results were limited to 
articles in English, with participants aged 18+.  The results were not limited to 
peer-reviewed articles so as not to exclude doctoral theses which have made an 
important contribution to this area of research.  However all studies were 
thoroughly scrutinised to ensure research quality. 
 
A total of 181 articles were identified via EBSCO, and 208 using ScienceDirect, 
Cochrane Library, Scopus and MEDLINE.  All titles and abstracts were examined 
for relevance and articles were included if clients were asked about some aspect 
of their experience of the neuropsychological assessment process.  As the 
literature is limited, both qualitative and quantitative research articles were 
included.  Articles that referred solely to experiences of diagnosis and post-
diagnosis adjustment or to experiences of people without neurodegenerative 
conditions or dementia were excluded.   
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1.5. Existing Research on the Experience of Neuropsychological 
Assessment 
 
The earliest known studies to consider the experience of neuropsychological 
assessment were conducted by Bennett-Levy et al., (1994) and Donofrio, Piatt, 
Whelihan and DiCarlo (1999).  For both studies, it has not been possible to 
establish if the sample included participants with neurodegenerative conditions, 
hence their exclusion from the subsequent literature review, however they have 
been summarised below to provide historical context. 
 
Bennett-Levy et al. (1994) involved 129 outpatients, with various diagnoses 
(including stroke and head injury) from five centres across Australia.  Participants 
who had undergone neuropsychological assessment 0-6 months previously, 
completed a Neuropsychological Assessment Questionnaire developed by the 
authors, mainly comprising of yes/no questions with the option to provide 
additional comments.  Overall 56% described their experience as positive, with 
91% describing it as positive or neutral.  Between 39%-60% of respondents felt 
adequately prepared for the length and purpose of the assessment respectively, 
yet a worrying 60% reported they were not told what to expect.  Most participants 
found it relevant (70%) and interesting (72%), with half reporting it was tiring 
(52%) and frustrating (47%).  A large proportion of participants (75%) reported 
little or no anxiety about the assessment.  In terms of feedback, 68% reported 
receiving feedback, yet only 26% received this in writing with most indicating they 
would have liked to. 
 
Bennett-Levy et al. (1994) concluded that a positive experience was dependent 
on the degree of reported preparation and perceived usefulness of feedback.  
Several recommendations were made, including that clients are adequately 
prepared, given an adequate rationale and provided with written, understandable 
feedback.  The authors acknowledged the lack of data regarding reliability and 
validity of the questionnaire, the overreliance on closed questions and omission 
of potentially important parts of the assessment process (e.g. qualities of the 
examiner), which may have impacted on the experience reported. 
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Donofrio et al. (1999) investigated client’s perceptions of feedback following 
neuropsychological assessments.  Sixty participants with ‘brain dysfunction’, 
referred to a neuropsychology clinic, were asked to complete a one-page 
questionnaire immediately following feedback.  All participants reported finding 
the feedback session helpful or very helpful, with 95% finding the 
recommendations helpful, and 96.7% finding a written summary helpful.  
Feedback was unaffected by participants gender, diagnosis or the clinician’s level 
of training.  This study indicates overall satisfaction with feedback and highlights 
the importance of it being summarised in written form.  Unfortunately, due to only 
a summary format being available, the quality of this study could not be 
appraised.   
 
More recently, Mountjoy, Field, Stapleton and Kemp (2017) conducted a service 
evaluation of an outpatient clinical neuropsychology service, although again the 
study did not specify whether the sample included people with neurodegenerative 
conditions.  Self-report questionnaires were developed and administered to 24 
clients and 17 carers/family members immediately following feedback and again 
after three weeks.  Of all responses, 81.5% and 90% were positive from clients 
and carers/family members respectively, with comments that the experience was 
‘very helpful’ and ‘interesting’.  Overall findings highlighted neuropsychological 
assessment was experienced as clinically meaningful, with 88% of clients 
reporting their symptoms made more sense afterwards, although this 
understanding appeared to ‘wear off’, with only 72.7% of clients reporting the 
same after three weeks.  Whilst this a likely consequence of legitimate memory 
problems and natural processes of forgetting, it was also mirrored in carers/family 
members reports, highlighting the importance of summarising findings for people 
to take away.  In terms of the studies rigour, the developed questionnaire’s 
psychometric properties remain unknown and a self-selecting bias may have 
been present. 
 
Following early studies, the literature has diversified with studies examining the 
experience of neuropsychological assessment in various populations, including 
people with suspected dementia (Keady & Gilliard, 2002; Robinson, 2016), 
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people with traumatic brain injury (TBI; Owen, 2012), children (Conniff, 2008), 
people with learning disabilities (Davidson, Smith & Burns, 2014) adults with 
attention-deficit/hyperactivity disorders (ADHD) and autism spectrum disorders 
(Holst, Nyman & Larsson, 2009), culturally deaf people (Smith, 2010), older 
adults (Krohne et al., 2011) and people from different cultures (Dudley, Wilson & 
Barker-Collo, 2014; Shepherd & Leatham, 1999).   
 
These studies used varying approaches, with some novel designs, for instance 
Conniff (2008) and Owen (2012) interviewed children and survivors of TBI 
respectively, and utilised interpretative phenomenological analysis (IPA) to 
explore experience of neuropsychological assessment.  In Conniff’s (2008) study, 
it emerged children experienced the reasons behind the process of testing as 
benign, although there was an overriding sense of uncertainty about what to 
expect and the implications of the testing.  Children described positive 
experiences relating to qualities of the examiner and the test environment, and 
negative experiences relating to the length of testing.  Overall children reported 
learning from the experience, although they found the varied difficulty of tests 
hard to manage, and described the experience as unusual and distinct from other 
testing experiences.   
 
Owen’s (2012) study highlighted the impact of the relationship with the examiner, 
with participants valuing a familiar examiner, who treated them as an equal, whilst 
an unfamiliar examiner caused uncertainty and anxiety.  Participants approached 
the test with a need to try their best, and reported a range of feelings, from 
anxiety, confusion and frustration, to eagerness and relief.  The tests were 
experienced as providing awareness regarding their injury, although participants 
spoke about factors that negatively affected the assessment, such as fatigue and 
a poor environment.  Both studies recommended pre-assessment meetings 
(including written information) to prepare clients, build rapport and explore the 
person’s feelings towards testing, as well as involving them directly in feedback 
sessions.  A full exploration and critique of this literature is beyond the scope of 
this thesis, hence only literature specific to the experience of people with 
neurodegenerative conditions will be presented below. 
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1.5.1. Existing Research on the Experience of Neuropsychological Assessment 
for People with Neurodegenerative Conditions 
The above studies have provided valuable information about the experience of 
neuropsychological assessment, yet there is a paucity of literature into the 
experience of neuropsychological assessment, from the viewpoint of clients with 
neurodegenerative conditions.  In fact, most research on neurodegenerative 
conditions focusses on the medical aspects, neglecting to consider the 
perspective of people with neurodegenerative conditions.  The literature search 
identified five relevant pieces of literature that met search criteria (see Section 
1.4), four studies explored experience of neuropsychological assessment via a 
survey or questionnaire (one in the context of a service evaluation and two in 
comparison to control groups) and one used IPA to analyse interviews. 
 
Westervelt et al. (2007) examined perceptions of 129 clients and 80 significant 
others who had undergone a neuropsychological assessment at an urban 
neuropsychology centre in the United States of America.  Participant’s diagnoses 
included dementia, epilepsy, TBI, tumour and demyelinating disease.  The 
surveys, designed by neuropsychology staff to assess patient satisfaction, were 
sent one month after the feedback session and comprised nine questions 
regarding scheduling of appointments, the assessor, the assessment 
environment, feedback session and recommendations.  Participants were invited 
to write comments and rate each item on a four-point scale ranging from ‘very 
much satisfied’ to ‘not at all satisfied’. 
 
Overall, clients and significant others viewed the neuropsychological assessment 
positively, with 71% and 76% respectively, reporting they were very satisfied, 
irrespective of the assessor’s experience.  Clients commented on their 
appreciation of sufficient time being spent reviewing results, finding a detailed 
understanding of strengths and weaknesses confirmatory, although they were 
unsure whether it helped them understand or deal with their condition.  Most 
reported they had followed, or planned to follow recommendations provided, 
although participants appeared more likely to follow recommendations that were 
simple, concrete and regarding patient safety, rather than pertaining to patient 
coping.  Negative comments focused on the environment (e.g. room temperature) 
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and length of assessment.  Unfortunately, with the studies inclusion of patients 
with a wide range of conditions, the views of people with neurodegenerative 
conditions makes up less than 5% of the sample and does not provide an 
account of their experiences specifically.  
 
Foran et al. (2016) developed a patient satisfaction scale as part of a service 
evaluation and explored satisfaction of 66 out-patients following 
neuropsychological assessment, in a hospital-based neuropsychology service in 
Australia.  Participants included in the postal survey, had mild to moderate 
cognitive impairments resulting from a variety of conditions, including dementia, 
TBI and MS.  The scale, initially comprised of 24-items based on previously 
available patient satisfaction measures and theoretical literature, was reduce to 
14-items following a focus group of 15 adult service users.  Participants were 
asked to rate each item on a five-point scale (ranging from ‘strongly agree’ to 
‘strongly disagree’), were asked how they received feedback and were 
encouraged to provided further comments regarding their satisfaction via the use 
of two open-ended questions. 
 
Overall satisfaction was high, although participants viewed the testing phase 
significantly more favourably over the pre-assessment and feedback phases.  
Female participants reported significantly lower satisfaction levels compared to 
males.  With regards to feedback, 44% discussed the results with their 
neuropsychologist, 38% with a third party (e.g. GP, referrer or family) and 18% 
reported receiving no feedback or being unable to recall feedback.  Thirty-two 
participants included additional remarks, with positive comments focusing on the 
clinician’s interpersonal communication skills such as their professional manner, 
organisational skills and explanatory style.   Dissatisfaction was reported with the 
service availability, physical environment and with feedback sessions being 
difficult to understand and emotionally draining.  This study highlights the 
importance of pre-assessment preparation to provide personalised explanation 
regarding rationale and expectations, to reduce anxiety and potentially increase 
validity of the testing.  Foran et al. (2016) recommend that whilst assessments 
are standardised, the way they are applied can be flexible and individualised, with 
oral and written feedback tailored to a person’s strengths and weaknesses. Yet 
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again, the studies broad inclusion of various conditions results in a small 
representation of people with neurodegenerative conditions, namely MS. 
 
The two survey-based studies cited above (Foran et al., 2016; Westervelt et al., 
2007) present with several limitations.  Due to low response rates, potential bias 
may exist in the sample, as responders may have been more likely to report 
positive experiences.  Besides, a lack of anonymity may have resulted in 
participants being reluctant to express dissatisfaction, especially in the study by 
Foran et al. (2016) where the survey focused on positive aspects on the 
assessment process.  As both studies were retrospective, they rely on 
participant’s memory, which may affect reliability of the data, and as the surveys 
psychometric properties have not been examined, the content and construct 
validity remain unknown. 
 
Rosado et al. (2017) examined perceptions of 218 clients on the day of their 
neuropsychological assessment at a neuropsychology clinic in Chicago.  
Participant’s diagnoses included stroke, head injury, dementia, MS, depression 
and ADHD.  A total of 84 participants (38.5%) repeated the questionnaires six 
weeks later, 49 of which had attended a subsequent feedback session and 35 
had chosen not to.  The self-report questionnaires asked participants regarding 
any changes in symptoms, functioning, ability to cope and satisfaction with 
services and recommendations.  The findings showed participants who returned 
for feedback reported greater understanding of their condition, improved quality 
of life and ability to cope, compared to those who did not attend for feedback, 
highlighting that feedback should be considered an indispensable component that 
positively influences patient outcomes.  As with the above studies, this study 
suffered high attrition and with participants not randomly allocated, selection bias 
may exist.  Furthermore, contextual factors that may have prevented attendance 
at feedback sessions, such as access to transport, child-care issues, increased 
financial burden and work responsibilities were not assessed. 
 
Longley, Tate and Brown (2012) developed a protocol for measuring 
psychological benefit of neuropsychological assessments in MS and 
subsequently presented results in a conference paper (Longley, Tate & Shaw, 
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2012).  The prospective single-blind randomised controlled trial (RCT) explored 
responses to recommendations by randomly allocating participants to either a 
neuropsychological assessment with feedback or a ‘sham wait-list’ control.  A 
total of 41 patients with MS and 35 caregivers were recruited from MS Australia.  
A variety of self-report questionnaires looking at the helpfulness and adherence 
of recommendations, demographics, MS status, psychological and cognitive 
variables, were administered via telephone, both prior to and after the 
neuropsychological assessment.  Overall both patients and caregivers rated 
recommendations as moderately to very helpful, with 69% of patients and 64% of 
caregivers reporting adherence.  There were indications that adherence may be  
predicted by caregivers’ ratings of the patient’s cognitive impairment and effort, 
although no findings were statistically significant.  Whilst this single-blind RCT 
endeavoured to be methodologically sound, it did not allow for participants to 
provide rich accounts of their experience and participants that agreed to take part 
may be have been generally more motivated to comply (and follow 
recommendations). 
 
With the studies considered so far (Foran et al., 2016; Longley, Tate & Brown, 
2012, Rosado et al., 2017; Westervelt et al., 2007) each is based in a single 
service, limiting generalisability of findings, and reliance on questionnaires means 
they mainly capture consumer satisfaction as a measure of quality assurance to 
evaluate service delivery.  Whilst some studies invited qualitative comments, all 
utilised closed questions to some extent, imposing areas of perceived 
importance, preventing other more relevant areas being raised, and potentially 
limiting rich nuanced descriptions of experience. 
 
Blake’s (2004) doctoral thesis was amongst the first to utilise IPA to explore 
experience of neuropsychological assessment from the patient’s perspective.  
Nine adults, with varying conditions including stroke, TBI and MS, were 
interviewed following neuropsychological assessment at an outpatient service in 
the UK.  Findings indicated patients were poorly prepared for neuropsychological 
assessment, however patients approached it with positive expectations that it 
would provide information to help understand and cope with impairments.  The 
relationship with the psychologists emerged as key in determining the quality of 
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their experience, and facilitated increased awareness of cognitive strengths and 
weaknesses.  Blake (2004) recommended patients be sent preparatory 
information in advance and explore with patients what they hope to gain from 
testing.  In line with IPA, this exploratory study recruited a small sample, hence it 
is not possible to make generalised claims about all patient’s experiences of 
neuropsychological assessment.  Furthermore, the homogeneity of the sample is 
questionable as several participants were awaiting feedback of results which 
arguably forms an important part of the process, and participants had varying 
conditions, hence may have experienced the process very differently. 
 
1.6. Summary 
 
Examining the existing literature highlights that neuropsychological assessments 
are rarely experienced as a neutral event, with the process often experienced 
positively, and frequently described as ‘helpful’, ‘interesting’ and facilitating 
awareness of cognitive strengths and weaknesses (Bennett-Levy et al., 1994; 
Westervelt et al., 2007).  Adequate preparation for the assessment and feedback 
of results, both verbal and written, emerged as important elements to reduce 
anxiety and improved outcomes for clients (Foran et al., 2016; Rosado et al., 
2017).  The assessment environment, service availability, length of assessment, 
fatigue, frustration and the clinician’s interpersonal communication were reported 
as having a noticeable impact on the experience of testing (Bennett-Levy et al., 
1994; Foran et al., 2016; Westervelt et al., 2007).   
 
Whilst the growing body of literature is beginning to provide insights, it 
tantalisingly leaves us with many questions and gaps in our knowledge.  For 
instance, several studies reported participants found the process helpful, yet did 
not specify what was learnt or in what ways it was meaningful in their everyday 
lives.  Furthermore, most of the studies are quantitative, utilising surveys and 
questionnaires, and whilst a small number include a qualitative element, very few 
are formally qualitative.  Hence, there is clearly scope for in-depth qualitative 
exploration of client’s accounts, which may shed light on how neuropsychological 
assessment may contribute to improved quality of life, how it changes patient’s 
views of themselves, or how qualities of the examiner may influence the process. 
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1.7. Rationale 
 
The literature review identified a paucity of research providing in-depth accounts 
of people’s experience of neuropsychological assessment.  Research has tended 
to recruit broad samples of participants with varying diagnoses from 
neuropsychology services, however as Bennett-Levy et al. (1994) points out, 
satisfaction will likely differ between client populations.  Yet to my knowledge, 
there is no known study that has specifically explored how a person with a 
neurodegenerative condition experiences the assessment process, and this 
forms the basis of the rationale for this study. 
 
Previous studies suggest the context of assessment may affect how it is 
experienced (Bennett-Levy et al., 1994), hence it is essential to consider the 
broader context of being assessed in relation to a neurodegenerative condition, a 
diagnosis which by its very nature is progressive.  As assessments are conducted 
over the course of worsening disease, people may perform poorly, and the testing 
may vividly highlight and act as a painful reminder of lost ability and the potential 
of continued future loss.  Furthermore, clients with neurodegenerative conditions 
may encounter specific disadvantageous features, for instance testing that 
requires fine motor skills in the face or motor symptoms.  Therefore, the 
experience for people with neurodegenerative conditions, may be very different to 
other conditions, in which the trajectory is one of recovery or stability.  
Furthermore, due to the progressive nature of the disease, people with 
neurodegenerative conditions are likely to return for further episodes of care 
across their lifetime, hence the importance of understanding their experience 
specifically, as it is likely to be one that is repeated, having the potential to further 
consolidate negative experiences. 
 
Furthermore, the current study considers specific methodological weaknesses of 
the previous research.  For instance, quantitative approaches cannot encompass 
the study of human experience (Moustakas, 1994), and besides, the use of 
structured questionnaires are more likely to pose difficulties for participants with 
possible cognitive impairments (Paterson & Scott-Findlay, 2002), providing 
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unreliable or superficial results.  Utilising qualitative interviews in the current 
study, provides participants a better opportunity to express the uniquely individual 
aspects of their experience, and gives voice to their unheard ideas, 
demonstrating their views are valued.  This constitutes an important basis for 
future research (Nochi, 1998), promoting participant welfare, shifting the power 
dynamic, so participants become treated as active “partner[s]…rather than as 
subjects” or passive recipients (Keady & Gilliard, 2002, p.24). 
 
Additionally, with the prevalence of neurodegenerative conditions set to increase 
rapidly (Bokde et al., 2011) and a trend towards increased provider accountability 
and emphasis on consumer satisfaction (Westervelt et al., 2007), it is crucial to 
consider how neuropsychological assessment can be most valuable.  It is hoped 
this research can inform clinical practice, raising clinician’s awareness of the 
patient’s experience, thereby improving the quality of the service provided.  For 
instance, if a clinician can be mindful of what a patient is experiencing, they can 
shape the assessment and delivery of results, to maintain patient involvement, 
enhance client’s understanding and maximise compliance with recommendations, 
ultimately benefitting the patient’s quality of life (Foran et al., 2016; Westervelt et 
al., 2007).  Finally, in context of funding pressures facing the NHS following a 
decade of austerity, it makes good business sense to pay attention to patient’s 
experience to demonstrate the value of clinical neuropsychology (Prigatano, 
2000; Westervelt et al., 2007). 
 
1.8. Research Aims and Questions 
 
This study aims to; 
 examine people with neurodegenerative condition’s accounts of the 
neuropsychological assessment and how they describe these 
experiences, 
 explore their understanding, meaning and perceived usefulness of the 
assessment, 
 address the gap in current research by contributing significantly to the 
evidence base through qualitative research. 
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The primary research question is; 
 What do people with a neurodegenerative condition say about their 
experience of neuropsychological assessment? 
 
The secondary research questions are; 
 How do they describe this experience? 
 How did the experience make them feel? 
 What was their understanding of why they were assessed? 
 What do they find helpful or unhelpful about the process? 
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2. METHOD 
 
 
2.1. Overview 
 
This methodological chapter will begin by outlining the epistemological framework 
adopted in this study and explore the rationale for selecting IPA as the qualitative 
tool of choice.  I will then consider the research design and procedure before 
discussing ethical considerations.  Lastly, I will describe data collection and 
analysis, including the reflexivity of the researcher. 
 
2.2. Epistemological and Ontological Position 
 
Epistemology refers to “the way in which people gain knowledge about the world 
and come to regard some beliefs as true and others as false” (McLeod, 2005, 
p.28).  Varying epistemological frameworks serve as lenses through which we 
view the world, each holding different assumptions that guide our thinking 
(Mertens, 2005).  The following epistemological positions – positivist, post-
positivist, critical realist and constructionist – can be viewed on a continuum 
between a scientifically objective versus a socially constructed world view.  
Positivism states there is an objective reality that exists independently of our 
representations and that phenomena can be predicted via valid ‘scientific’ inquiry.  
However, in its pursuit of objectivity, positivist researchers risk treating 
participants as objects, failing to acknowledge their own position in the research 
(Robson, 2011).  Post-positivism accepts reality can only be measured 
imperfectly and will be influenced by the researcher’s beliefs and values, yet 
similarly to positivism, is a reductionist and deterministic philosophy.  Critical 
realism takes the position that whilst there is a ‘reality’, it must be considered 
within broader historical, social, political and cultural contexts, hence it can 
explain how people may experience the same situation differently depending 
upon the meanings they attach to the situation (Willig, 2008).  Finally, social 
constructionists assume there is no one truth, but multiple realities constructed 
socially, via language and within historical, cultural, political and gender norms. 
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In relation to the current study, the origins of qualitative approaches lie within the 
realm of post-positivist approaches, hence a critical realist epistemology was 
adopted.  This will impact assumptions about what the data can tell us, shaping 
the research questions and ultimately influencing my ‘gaze’ as a researcher 
(Smith et al., 2009).  The critical realist perspective accepts there is a stable, 
external world that exists independently of human conceptualisation (Danermark, 
Ekström, Jakobsen & Karlsson, 2002).  For instance, this study does not deny the 
reality of neurodegenerative conditions, including the progressive and irreversible 
degeneration of neurones and the resulting symptomology, nor does it deny 
people’s lived experience of neuropsychological assessment.  At the same time, 
critical realism acknowledges the way reality is perceived, particularly in the 
social realm, is filtered through our own and other’s life experiences, and hence 
depends on individual beliefs and expectations (Bunge, 1993).  For instance, the 
study acknowledges that participants may attach different meanings to their 
experience, and that my interpretations as a researcher will be influenced by my 
own experience.  Finally, a critical realist approach recognises that whilst 
constructs, such as the various neurodegenerative diagnoses and cognitive 
domains, hold some basis in reality, they are also heavily shaped by the broader 
social, cultural and political context. 
 
2.3. Selecting a Methodology 
 
In keeping with the research aims and epistemological framework, this study will 
use qualitative analysis in the form of IPA, which is predominantly underpinned by 
a critical realist position (Shinebourne, 2011).  There is a growing body of IPA 
research within clinical, counselling and health psychology demonstrating its 
value in psychological research, with detailed guidelines (Smith, Flowers & 
Larkin, 2009) facilitating its use with ‘novice’ researchers.  It acknowledges an 
interactive element between the researcher and participants, and is well suited to 
capture in-depth accounts of individual’s experience.  Furthermore, I was drawn 
to IPA as it recognises data is generated as a product of a participant-researcher 
interaction, flattening power imbalances and acknowledging the researcher’s 
explicit role in interpretative input which requires creativity and reflexive 
awareness (Larkin, Watts & Clifton, 2006). 
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2.3.1. Qualitative Analysis 
Qualitative methodologies aim to understand and represent people’s subjective 
experience, as close as possible to their perspective (Elliott, Fischer & Rennie, 
1999) and lend themselves to exploratory research.  This is particularly important 
in this study as people with neurodegenerative conditions experience of 
neuropsychological assessment has been a relatively neglected area of research, 
resulting in a deficiency of psychological knowledge (Smith, 1996).  Qualitative 
research has the potential to give voice to previously unheard voices (Willig, 
2008) and discover reasons for the outcome of interventions (Starks & Brown 
Trinidad, 2007). 
 
2.3.2. Interpretative Phenomenological Analysis 
Developed by Smith and Osborn (2003) and Smith et al. (2009), IPA seeks an 
‘insider perspective’, examining human lived experience in detail (Pietkiewicz & 
Smith, 2012).  It was considered a suitable methodology, as the aim of IPA is not 
to examine a predetermined hypothesis using a large sample, but to explore in-
depth how a limited number of participants make sense of their world (Smith & 
Osborn, 2007).  It views people as experts on their own experiences who can 
“offer researchers an understanding of their thoughts, commitments and feelings 
through telling their own stories, in their own words” (Reid, Flowers & Larkin, 
2005, p.20).  IPA lets people speak for themselves, whilst recognising it cannot do 
this directly or completely as the researchers own values, experiences and 
beliefs will influence interpretations and sense-making (Malterud, 2001; Smith, 
1996). 
 
IPA, with its theoretical roots in transcendental philosophy, is founded on three 
principles; phenomenology, hermeneutics and idiography (Smith, 2011).  
Phenomenology is a philosophical approach to the study of experience and is 
concerned with what a human experience is like.  Hermeneutics refers to the 
theory of interpretation which occurs at several stages throughout the research 
process, firstly by participants making sense of their worlds and subsequently by 
the researcher trying to make sense of the participant trying to make sense of 
their world (double hermeneutic process) (Smith & Osborn, 2007).  Idiography is 
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concerned with the ‘particular’ (‘particular’ experiential phenomena, from the 
perspective of ‘particular’ people, in a ‘particular’ context, with a ‘particular’ sense 
of detail), as opposed to making claims at a group level (Smith et al., 2009).  
Hence IPA utilises small purposively-selected samples, focussing on distinctions 
or commonalities across individual’s experience, before cautiously generalising 
without taking claims out of context, to help gradually build a picture for larger 
populations (Smith et al., 2009). 
 
2.3.3. Limitations of IPA 
Indeed, IPA has limitations in that it describes people’s lived experience without 
attempting to explain it.  However, it could be argued, to begin explaining an 
experience, you need to understand how individuals views their experience.  In 
addition, IPA risks underplaying the role of language as constructing, not merely 
describing reality, and whilst it acknowledges the participants and researchers 
own values influence how an experience is described and interpreted, there is 
limited guidance about how to integrate this into the research process (Willig, 
2008). 
 
2.3.4. Why IPA Over Other Qualitative Approaches? 
The phenomenological approach in IPA was deemed the most suitable approach 
to meet the research aims, over numerous qualitative alternatives, including 
Grounded Theory (GT), Thematic Analysis (TA), Discourse Analysis (DA) and 
Narrative Analysis (NA).  GT originates from a sociological approach, rather than 
a psychological one and focuses on generating theoretical explanations that 
captures social processes, rather than understanding of individual experience 
(Starks & Brown Trinidad, 2007).  It aims to achieve saturation, which would be 
logistically difficult and unnecessary to understanding people’s lived experiences.  
TA focuses on identifying patterns of behaviour across larger samples and is 
mainly descriptive (Braun & Clarke, 2006), whereas IPA is better suited to a 
higher level interpretive complexity and its idiographic stance can capture 
richness of experience (Vaismoradi, Turunen & Bondas, 2013).  DA attempts to 
understand the role of language in constructing reality and negotiating 
knowledge, meaning and identities, and similarly NA is used to understand how 
people use language or ‘self-accounts’ to construct and interpret the world 
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(Burck, 2005).  Whilst IPA acknowledges the role of language, it is not concerned 
with every utterance, and allows greater flexibility to consider how language 
assists meaning making of experience (Smith et al., 2009). 
 
2.4. Design 
 
The study utilised a cross-sectional qualitative design, utilising IPA to analyse 
data from semi-structured interviews with eight participants. 
 
2.4.1. Service User Consultation 
During the study development, a service user consultation was arranged to 
obtain feedback regarding the research documents and interview schedule.  The 
only suggested amendments, which were duly made, were to reduce repetition in 
the documentation and reduce the amount of time following the interview during 
which participants can withdraw their data. 
 
2.5. Participants 
 
2.5.1. Recruitment 
Participants were recruited from a community neuropsychology service in central 
London that accepts referrals locally.  Recruiting via a single service, and 
attending weekly multi-disciplinary team meetings during the recruitment phase, 
allowed for development of good working relationships with the team.  This 
enabled clinicians to be reminded of the study (see Appendix A for staff 
information sheet), gain answers to questions and feel comfortable in suggesting 
potential participants.  The clinical psychologists, who routinely completed 
neuropsychological assessments, approached potential participants that fulfilled 
inclusion criteria (see below) to discuss the study and, if they gave permission, 
provided their contact details to me.  Potential participants who agreed to be 
contacted were subsequently sent a cover letter and participant information sheet 
(see Appendix B and C) and later contacted via email or telephone to arrange the 
interview if they wished to take part. 
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2.5.2. Sample 
Qualitative interviews generally produce large volumes of data, requiring detailed 
and extensive analysis, hence it is appropriate to recruit a small number of 
participants to ensure voices are not lost (Larkin et al., 2006). 
For IPA specifically, Smith et al. (2009) suggest conducting between 4-10 
interviews for doctoral research, which allows for more detailed analysis of 
similarities and differences across cases.  Based on this and peer review 
feedback, it was decided eight participants would be recruited for the study. 
 
In line with recommendations for IPA (Smith et al., 2009), the aim was to recruit a 
reasonably homogenous sample, selected purposively due to the experience of a 
similar life event.  This led to deliberations about the ways in which individuals 
differ from one another and how much variation can or needs to be contained to 
enable analysis of a phenomenon.  As the population is likely to be small, this 
was largely dictated by a pragmatic need to balance homogeneity of the sample 
with the availability of potential participants, hence inclusion criteria were carefully 
selected to be inclusive.  Nevertheless, reasonable homogeneity was achieved in 
that all participants were adults with a neurodegenerative condition for which they 
had undergone a neuropsychological assessment.  Furthermore, the intention 
was not to achieve a representative sample, as IPA aims not for generalisability, 
but to “say something in detail about the perceptions and understanding of this 
‘particular’ group rather than prematurely make more general claims” (Smith & 
Osborn, 2007, p.55). 
 
2.5.3. Inclusion Criteria 
 Adults (18+)1 who have a neurodegenerative condition, and have 
undergone a neuropsychological assessment subsequent to their 
diagnosis (>1month, <2 years since assessment) which they can 
remember. 
                                                     
 
1 An upper age limit was not applied as it was felt a homogenous group could be achieved without 
an arbitrary limit which discriminates against older adults (McMurdo, 2012), and would exclude a 
large proportion of eligible participants. 
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 Participants should not have a pre-existing cognitive deficit that is 
unrelated to the potential deficit being assessed, or have exhibited 
possible confounding factors (e.g. suspected low effort). 
 Participants should be able to verbally express themselves sufficiently to 
answer interview questions. 
 Participants should be able to speak and understand English.2 
 Participants should have capacity to consent (see ethics section). 
 
2.5.4. Study Sample and Demographic Information 
Eight participants were recruited, all whom met the inclusion criteria (see Table 1 
below for more information).  More detailed profiles of individual participants have 
not been provided to maintain confidentiality. 
 
Table 1: Demographics of participants 
Sex Five females, three males 
Age Ranged from 44-77 years 
Ethnicity Six British, one Irish, one Maltese 
Neurodegenerative condition Four PD, two MS, one MSA, one 
myotonic dystrophy 
Time since diagnosis (years) 2-24 years 
 
2.6. Ethical Considerations 
 
2.6.1. Ethical Approval 
Ethical approval for the study was granted by the University of East London’s 
(UEL) Ethics Committee, the relevant NHS Research Ethics Committee and the 
NHS Health Research Authority (see Appendix D). 
 
 
 
                                                     
 
2 As most neuropsychological tests are not appropriate for use cross culturally, any assessment 
on a person who cannot speak English would rely on a limited selection of tests, and 
subsequently it is likely their experience of testing would be very different. 
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2.6.2. Informed Consent 
Informed consent was obtained from each participant prior to conducting the 
interview.  This was achieved by providing potential participants with an 
information sheet and offering them the opportunity to ask questions about the 
study prior to signing the consent form (see Appendix E).  To ensure participants 
did not feel pressured to take part, the information sheet and clinical 
psychologists initially approaching participants highlighted that participation was 
voluntary, independent of the service and would not affect their current or future 
care. 
 
Due to the nature of neurodegenerative conditions, clients who lacked capacity to 
consent due to the severity of their condition, were unfortunately not invited to 
participate.  To not unnecessarily exclude participants with cognitive deficits, the 
information sheet and consent form were, as much as possible, kept short, 
simple and free of jargon.  Adaptions to the consent procedure were offered to 
participants, such as reading the information sheet to participants or re-visiting 
consent on multiple occasions to ensure a desire to participate was consistently 
conveyed across research encounters (Nygard, 2006). 
 
2.6.3. Right to Withdraw 
Participants could withdraw all their data up until the point of data analysis (one 
week after interview).  After this, data may have been included in data analysis, 
so participants were offered the opportunity to review accuracy of transcripts or 
request direct extracts from transcripts not be included in the final report (as 
recommended in Smith et al., 2009) 
 
2.6.4. Confidentiality and Anonymity 
Anonymity was guaranteed as names and identifying features were altered in 
transcripts, extracts and resulting publications, and participants were assigned an 
identification number, of which I had sole knowledge.  Participant’s identification 
numbers were stored securely, alongside consent forms and participant record 
forms, in a locked filing cabinet at UEL.  These were kept separately from audio 
recordings and transcribed material, which were stored electronically on a 
password-protected computer.  I was responsible for transcribing the interviews 
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and transcripts were accessible only to myself, my academic supervisor and 
examiners.  Audio-recordings and consent forms will be destroyed following 
examination of the thesis. Transcripts and data analysis output will be kept 
securely for a five-year period after the research submission, after this time they 
will be destroyed in accordance with the Data Protection Act (1998). 
 
Participants were informed about confidentiality and its limits, including that if 
there were any concerns about participant’s safety, confidentiality would be 
broken to consult with the clinical supervisor and where possible would be 
discussed with the participant beforehand.  The thesis will be shared with the 
community neuropsychology service from which participants were recruited, so to 
reduce the possibility that extracts may be identifiable by readers from within the 
service, extracts were selected carefully.  On the contrary, participants may wish 
to be openly identified within an academic forum, however this was discouraged 
to protect their own future anonymity and the anonymity of other participants.  
 
2.6.5. Risks and Benefits 
It was not anticipated the study would cause harm to participants, however if 
participants became distressed during the interview, they were reminded their 
participation was voluntary and they were free to take a break, reschedule or 
withdraw from the study at any time without needing to provide a reason.  At the 
end of each interview, time was allocated for debriefing and participants were 
offered contact details for supporting agencies should they wish to seek further 
support (see Appendix F).  The clinical supervisor from the community 
neuropsychology service was informed if participants had shown signs of distress 
during the interview.  I attended regular supervision with the clinical supervisor to 
help manage feelings that arose from distressing interview material to prevent 
‘researcher fatigue’ (Dickson-Swift, James, Kippen & Liamputtong, 2007). 
 
There were potential benefits to taking part in the study, including an opportunity 
to reflect on past experiences which may be therapeutic (Birch & Miller, 2000) 
and to have their voices heard which could help others in their position in the 
future.  A small financial incentive (£10 Love2Shop voucher) was offered, plus 
travel costs of up to £5 were reimbursed.  This communicated to participants that 
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their time was valued and reduced power imbalances, whilst not risking undue 
inducement (National Research Ethics Advisors’ Panel, 2014).   
 
2.7. Data Collection 
 
2.7.1. Semi-structured Interviews 
A semi-structured interview schedule was developed (see Appendix G) based on 
previous research (Owen, 2012) and relevant guidance (Smith et al., 2009) which 
recommended interviews as the best way to collect data for an IPA study (Smith 
& Osborn, 2007).  The schedule acted as a guide, encouraging participants to 
recollect, talk in-depth and immerse themselves in their experience, whilst 
allowing me flexibility to modify responses and follow up interesting issues that 
emerged.  To avoid interrupting the flow of conversation, notes of key points to 
follow up were made (using participants own words where possible), however 
notes were kept to a minimum so as not to limit eye contact, disturb non-verbal 
communication or in-depth listening (Mertens, 2005).  The interview schedule 
consisted of a relatively small number of open-ended questions and avoided 
hidden assumptions that may have led participants towards certain answers 
(Pietkiewicz & Smith, 2012).  Verbal input was kept to a minimum, with more 
specific questions only asked to check understanding.  The same interview 
schedule was used for each interview; however, the ordering or phrasing of 
questions was adapted depending on how participants were responding.  I was 
alert to shifts in the interview dynamic, towards a more affective, specific or 
disclosing atmosphere, following which I would revisit earlier topics to allow them 
to be gone into in more depth (Smith et al., 2009). 
 
2.7.2. Challenges and Strategies for Conducting Interviews 
Conducting qualitative research with individuals living with a neurodegenerative 
condition posed numerous unique challenges resulting from the disease process 
or side effects of treatment (LaDonna & Ravenek, 2014).  I reflected that many 
people with neurodegenerative conditions experience cognitive deficits including 
attentional difficulties, slow information processing, word finding difficulties and 
fatigue, meaning they may struggle with open-ended questions (Paterson & 
Scott-Findlay, 2002).  However, as noted by Holsteing and Gubrium (1995), 
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“participants competence as interviewees is determined not as the ability to 
recount the details of their experience but, the way in which they organise the 
meanings they convey” (p.19), therefore with careful consideration and flexibility, 
they can make important contributions to research.  In addition, previous 
research highlights how IPA can be utilised with groups who may be considered 
unable to provide a ‘rich’ account, such as with children (Conniff, 2008), or high-
functioning individuals with Autistic Spectrum Disorder (Williams, 2004). 
 
Smith et al. (2009) suggest an IPA interview schedule for an articulate adult 
contain 6-10 open questions with prompts, to generate between 45-90 minutes of 
conversation.  It is recommended this number be reduced for people with 
possible cognitive difficulties (LaDonna & Ravenek, 2014; Paterson & Scott-
Findlay, 2002), hence I decided to include four main questions, with numerous 
prompts to be used only if needed (many of which were different ways of asking 
the same question).  Additional strategies employed were; 
 being flexible about time of day, 
 orientating participants to the neuropsychological assessment (i.e. the 
pen and paper tests you underwent that assessed your thinking skills) 
 asking the most important questions towards the beginning, 
 asking one question at a time and repeating if necessary, 
 following the pace of the participant, 
 minimising distractions, 
 interviewing over multiple sessions if needed, 
 allowing participants to go ‘off-topic’ for a few minutes before steering the 
conversation back to information relevant to the topic under study.  Whilst 
this strategy could be critiqued for letting the interview schedule drive 
analysis (Smith et al., 2009), it was often a necessary and valuable 
strategy to gently guide participants back to the topic. 
 
For participants with movement disorders, I was mindful that as a relatively 
inexperienced researcher in this field, involuntary movements may prove 
distracting.  To ensure participants were as comfortable as possible, I provided a 
stationary chair and encouraged participants to let me know if they were unable 
to sit or stand for prolonged periods.  For participants with poor voice volume 
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and/or quality and to minimise noises on the recording which may result from 
participants unintendedly hitting the surface where the recorder is positioned, two 
high quality digital recorders were placed thoughtfully during the interview 
(LaDonna & Ravenek, 2014).  Furthermore, some individuals with PD may 
experience ‘masked face’ or loss of facial expression which provides important 
non-verbal cues in social interactions.  To facilitate mutual understanding and 
empathy I often asked, “How does this make you feel?” to overcome difficulties 
related to reduced non-verbal communication (LaDonna & Ravenek, 2014).   
 
2.7.3. Interview Focus 
The interview schedule consisted of four parts; 
1. Participants were asked to tell me what they remembered about the 
neuropsychological assessment they underwent.  This was to introduce the 
topic and find out about their experience of being assessed, including their 
understanding of the purpose of the assessment. 
2. Participants were asked to tell me their experience of being assessed.  
This was to find out how they viewed the experience, including the experience of 
the assessment environment and assessor, how it made them feel and whether 
certain parts were particularly memorable. 
3. Participants were asked about the feedback of results from the 
assessment.   This was to explore how feedback was delivered, the implications 
of results and how this made them feel. 
4. Participants were asked about the outcome of the assessment.  This was 
to determine whether they found the assessment useful or meaningful and 
whether anything had changed as a result. 
 
2.7.4. Interview Process 
All interviews took place in a quiet confidential room at either the community 
neuropsychology service, the university site or the participant’s home, with the 
appropriate lone-working policies followed.  Prior to the interview commencing, 
the information sheet was revisited and participants were given the opportunity to 
ask questions, before signing the consent form and completing the participant 
record form to collect demographic information (see Appendix H).  Throughout, I 
strived to establish rapport with participants, drawing on my experience as a 
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clinician, providing reassurance about what was required and listening 
empathetically to allow them to feel comfortable and relaxed.  
 
Interviews were expected to last 40-60 minutes, which is ample for collection of 
sufficiently detailed data (Smith et al., 2009).  Interviews were audio-recorded, 
with participants talking for an average of 58 minutes.  Following the interview, 
participants were given the opportunity to raise concerns and reflect on the 
interview experience (Meyer, 1998).  At this point, to reduce the power differential 
between myself and the participant, I welcomed feedback about how I could 
improve the interview.  Lastly, participants were offered the option to receive a 
summary of findings from the study following its completion.  None of the 
participants became distressed in the study. 
 
2.8. Data Analysis 
 
2.8.1. Memo Writing 
Immediately after each interview, I recorded notable themes and reflected on my 
initial observations of the participant, context and setting of the interview.  As a 
novice interviewer, I continually evaluated my interviewing style as part of an 
iterative process to refine my technique. 
 
2.8.2. Transcription 
Interviews were transcribed verbatim, using a simple transcription scheme 
(adapted from Bannister et al., 2011; see Appendix I). 
 
2.8.3. Analysis 
The data was analysed using IPA, following guidelines described by Smith et al., 
(2009) and Smith and Osborn (2007).  The first stage of analysis involved reading 
and re-reading transcripts, noting initial points of interest, connections, 
contradictions and preliminary interpretations relating to the research question in 
the right-hand column.  Subsequently transcripts were re-visited in a systematic 
manner to create a deep and rich level of analysis and inferences were made 
about the nature, meaning and context of participant’s experience.  Exploratory 
comments remarked upon descriptions (keywords, phrases, explanations, figures 
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of speech and emotional responses), linguistics (pronouns, pauses, laughter, 
repetition, tone, fluency and metaphors) and conceptualisations (overarching 
interpretations, ‘meta’ views). 
 
The second stage involved identifying and labelling emerging themes, recording 
them in the left-hand column (see Appendix J for worked example).  Where 
possible participants own words were used, in keeping with the 
phenomenological nature of IPA.  These themes guided readings of subsequent 
transcripts, although I continually looked for new or contradictory themes and 
referred to the right-hand column to ensure my interpretations were grounded in 
participant’s accounts (Willig, 2008). 
 
In the third stage, connections were made between emerging themes, with some 
themes acting as magnets pulling others towards them, in a bid to facilitate 
sense-making.  As Smith et al. (2009) suggests, related themes were clustered 
using electronic cut and paste exercises over several weeks to group them into 
potential subordinate and super-ordinate themes.   
 
Finally, following the analysis of each interview individually, a similar process was 
followed to amalgamate themes across interviews.  This process involved 
continually checking interpretations and resulted in a list of subordinate and 
super-ordinate themes (Willig, 2008; see Appendix K).  Key quotations to 
illustrate each theme has been expanded into a narrative account to form the 
basis of the Results chapter. 
 
2.9. Reflexivity 
 
In qualitative research, it is important for researchers to be openly reflexive about 
preconceptions, biases or assumptions they hold about a topic, as this can 
increase a studies rigour (Polgar & Thomas, 1991).  According to Willig (2008), 
there are at least two types of reflexivity; personal reflexivity and epistemological 
reflexivity.  Personal reflexivity is an awareness of how the research process is 
affected by the researchers own professional and personal, cultural and political 
values, beliefs and experiences.  Epistemological reflexivity is an awareness of 
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how a researcher’s ontological expectations (what they anticipate capturing 
during the research) affects the research process (Robson, 2011). 
 
As Malterud (2001) states “a researcher’s background and position will affect 
what they choose to investigate, the angle of investigation, the methods judged 
most adequate for this purpose, the findings considered most appropriate, and 
then framing and communication of conclusions” (p.483-84).   Whilst it is 
impossible to eliminate one’s perspective entirely, being self-reflective allows 
researchers to acknowledge and ‘bracket off’ pre-conceptions that influence the 
interpretation of data.  To optimise reflexivity and transparency, a journal was 
used to record personal reflections (Ortlipp, 2008; Vicary, Young & Hicks, 2016). 
 
2.9.1. Personal and Professional Position 
I am a 28-year-old white British female, who grew up in a largely white British, 
working/middle class outer London suburb.  My previous experiences working in 
psychology for 4 years, combined with my clinical psychology training at UEL, 
have undoubtedly influenced my personal values and led me to favour social 
constructionist and critical approaches in clinical practice and research.  My own 
position in approaching this research is one of a critical realist; acknowledging the 
reality of individuals experience, whilst emphasising the importance of historical, 
social, political and cultural contexts in shaping how individual’s experiences are 
constructed. 
 
My keen interest in the process of neuropsychological assessment, developed 
prior to training, through my work in various settings, where I administered 
neuropsychological assessments.  I was often struck by how differently each 
person experienced testing, and witnessed first-hand the various reactions during 
feedback sessions.  Whether diagnostically driven or for functional assessment, I 
recall feedback sessions and subsequent reports being filled with jargon, 
sounding very medically orientated, meaning as a professional I was often placed 
in the position of ‘expert’.  I recall feeling frustrated as the lack of collaboration or 
support for clients and their families throughout the process, which had a lasting 
impact on me. 
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As my training progressed, I noticed a disparity between my social constructionist 
approach and sometimes how neuropsychological assessments were used in a 
concrete or arbitrary way.  Since then I have been inspired by fellow 
professionals who have skilfully combined neuropsychological assessment with a 
more collaborative systemic approach.  I am therefore approaching this research 
with the belief that neuropsychological assessment can be a useful and 
meaningful tool, but that it should be done with consent (not done to), and that it 
may not be useful for everyone.  My position is one of curiosity; what is the 
experience of neuropsychological assessment - if it is useful, why and how so, 
and if it is not useful, why and what could help? 
 
Following a discussion with my supervisor about my area of interest, he pointed 
to the paucity of qualitative research in this area, especially with people living with 
neurodegenerative conditions.  Through my experience, I have been committed 
to giving voice to marginalised groups and I was surprised at the lack of studies 
focussing on the experience of those living with a neurodegenerative condition.  I 
have relatively limited experience in working with people with neurodegenerative 
conditions and in some respects, this has allowed me to stay close to individual’s 
experience without my own views influencing my interpretations (although 
inevitably I will hold assumptions on related discourses e.g. cognitive abilities, 
disease, death).   
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3. RESULTS 
 
 
3.1. Overview 
 
This chapter outlines the four superordinate and sixteen subordinate themes that 
emerged from analysis, reflecting the eight participant’s described experiences of 
neuropsychological assessment.  In the following narrative account, each theme 
is presented and explored in detail, illustrated using verbatim extracts from the 
interview transcripts of each participant.  Within each theme individual 
participant’s experience will be discussed, including any commonalities and 
differences.  Themes are neither exclusive nor all-encompassing, so whilst ideas 
relating to one theme may resonate with other themes, they cannot cover every 
possible aspect of each person’s experience.  It is worth noting that the themes 
represent one possible account of participant’s lived experience, as seen through 
my lens as a researcher.  Other researchers may have focused on different 
aspects of the accounts; hence this account offers a personal and subjective 
interpretation.   
 
Occasionally, the verbatim extracts have been minimally altered to improve 
readability.  Where phrases are truncated to omit pauses in speech or portions of 
the text without altering the meaning, this is indicated using ellipsis (…), and 
where the subject of an extract is absent, parenthesis have been added for 
reference in square brackets.  Each participant has been assigned a pseudonym 
and participant’s specific diagnoses have been omitted to maintain anonymity.  
Each extract is referenced to the participant and corresponding line number on 
the transcript. 
 
3.2. Superordinate and Subordinate Themes 
 
The superordinate and subordinate themes that emerged from analysis are 
summarised in Table 2.  A table illustrating the recurrence of each theme within 
participant’s accounts is provided in Appendix L. 
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Table 2: Summary of themes representing people with neurodegenerative 
condition’s experience of neuropsychological assessment 
 
 
Superordinate Themes 
 
 
Subordinate Themes 
Expectations of assessment 
 
Deciding to undergo assessment 
To measure cognitive decline 
Anticipating understanding and coping 
advice 
 
Relationship with clinician 
 
Positive clinician qualities supported 
coping 
Familiarity and trust 
Expertise and power 
 
Experience during testing 
 
Subjective awareness of performance 
Emotional response to testing 
Coping with testing 
Intense and prolonged 
Importance of environment 
 
Outcome of assessment 
 
Communication of results 
Meaning of results 
Emotional impact of results 
Coping strategies provided power and 
control 
Future implications 
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3.3. Expectations of Assessment 
 
This theme concerns participant’s beliefs about the nature and purpose of 
assessment.  Overall, despite trepidation in deciding to undergo the assessment, 
participants described an overriding desire to measure possible cognitive 
difficulties, and to seek explanations and advice regarding coping with deficits.  
 
3.3.1. Deciding to Undergo Assessment  
In deciding whether to undergo assessment, participants described a sense of 
trepidation as they anticipated possible outcomes.  In the following extract, Arthur 
suggests he ‘might not like’ the outcome of the assessment: 
 
I knew I was going to be on some sort of learning journey, I might not like 
it, but I’ll be on a learning journey, I was geared up for that. (Arthur:334-
337) 
 
In this extract, Arthur appears to value the possibility of learning, despite the 
potential for a negative outcome, and uses the metaphor of travelling, as if the 
assessment will move him forward to a worthier ‘destination’.  Unable to stop the 
momentum started by his request, he describes mentally preparing himself to 
face the consequences, implying a strong motivation or pressure to complete the 
assessment.  Lisa also describes her fear: 
 
You think “oh goodness this might open a can of worms”. (Lisa:384-385) 
 
In using this idiom, Lisa articulates concern that her attempt to gain reassurance 
regarding her cognitive abilities, may result in new unexpected problems.  
Despite apprehension, participants sensed they ‘should’ do the assessment: 
 
I didn’t have to do it but, I knew that I ought to do it. (Lisa:754-757) 
 
It’s got to be done, and if you don’t ask the questions, how are you going 
to get answers. (Jean:395-397) 
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These extracts illustrated participant’s apparent moral judgement of 
neuropsychological assessment as the ‘right’ thing to do.  Indeed, Jean notes she 
would not benefit from answers, were it not for completing the tests.  Hence 
participants seemed to experience an internal struggle weighing up the potential 
unwanted outcomes against a desire to undergo the assessment.   
 
This may have been exacerbated by the medical context, where dominant 
discourses describe tests being unpleasant, yet necessary (e.g. blood test).  
Hence, participants also appeared to experience expectation to consent from 
external sources.  As Arthur admits: 
 
What I wanted to do, and I was told to do, is be able to see if my condition 
is deteriorating. (Arthur:5-7) 
 
Whilst Arthur’s own desire to complete the assessment is clear, he acknowledges 
he was ‘told to do’ so, suggesting participants experienced an expectation not 
only from themselves, but directly stated by others, (although in this instance we 
remain unclear who).  This left me questioning whether participants felt able to 
decline a neuropsychological assessment if offered. 
 
3.3.2. To Measure Cognitive Decline 
Most participants spoke about undergoing assessment to discover possible 
cognitive deficits, and measure potential progression of their condition.  In the 
following extract, Arthur uses an analogy with his previous occupational role, to 
describe his desire to ‘actually measure…rather than speculate’: 
 
What I wanted to do…is be able to see if my condition is deteriorating or is 
static or is improving, so what I wanted, and this is typical management, 
you know, I want something I can actually measure. (Arthur:5-10) 
 
Thus, it appears Arthur anticipated the neuropsychological assessment would be 
similar to his management role which could be broadly defined as ‘controlling 
things or people’.  This concept of control is further asserted, as the desire to 
record a baseline measurement seems to be his request.  Arthur’s description of 
Chapter 3: RESULTS 
 
47 
 
potentially measuring improvement, seems to suggest he is keeping a positive 
outlook.  In contrast, some participants, aware of difficulties with cognitive ability, 
saw the assessment as a chance to quantify progression: 
 
I was quite interested to find out how much of my memory was affected, 
cos I do know that my memory was affected by the [neurodegenerative 
condition]. (Sheila:11-14) 
 
It’s interesting to know…how things are developing with your brain, you 
know you become aware like with something like [a neurodegenerative 
condition] that things are starting to deteriorate, and you know it’s 
interesting then to be able to maybe get proof of, what you might be 
experiencing in life. (Helen:209-214)  
 
Early cognitive symptoms can often be subtle, even significant cognitive 
impairments may not be immediately apparent and can be considered a ‘hidden’ 
disability, hence the concept of ‘proof’ was clearly important for Helen.  The 
description suggests the assessment would confirm the existence of cognitive 
difficulties as ‘fact’, helping to explain associated impacts on daily functioning, 
proving she wasn’t “lazy”(322), both to herself and others.  Other participants 
corroborated the difficulty in judging their own possible cognitive decline: 
 
Of course, that’s the one thing you can’t see is your head, if you know 
what I mean. (Lisa:152-154) 
 
Well, it’s easy to see that it’s difficult for me to get in and out of this chair, 
it’s obvious that I haven’t got the strength and the mobility I had, but like I 
said to you, in terms of my thinking, it’s quite difficult to measure. 
(Stephen:475-479) 
 
Stephen, in comparing his cognitive ability to his physical deficits, vividly captures 
the relative obscurity of cognitive deficits.  Thus, participants expected the 
assessment to help make the invisible, visible.  Stephen goes on to note: 
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The joint aim of [the assessment] was just seeing where I was from a 
cognitive point of view, cos that’s one thing you can probably measure 
quite accurately. (Stephen:111-114) 
 
Whilst this appears to directly contradict Stephen’s earlier statement, on closer 
inspection, his use of the word ‘you’ in the latter extract, suggests whilst he 
struggled to measure his own cognitive ability, the clinician using a 
neuropsychological assessment could provide an accurate measure.   The 
participants differed in their views about who the measurement was for, with 
Stephen acknowledging “in my mind, it was really selfish”(64), whereas Jean 
comments: 
 
Basically, because I’d been diagnosed with [a neurodegenerative 
condition] and they wanted, I suppose, to find out if it was getting any 
worse. (Jean:19-22) 
 
Whilst Stephen seemingly says that his experience of the assessment was solely 
for his benefit, Jean interestingly remarked it was ‘they’ who would benefit.  It 
appeared for her the tests represented a tool utilised by powerful experts to 
ascertain her possible decline, allowing professionals to find out how to help her. 
 
3.3.3. Anticipating Understanding and Coping Advice  
The participants voiced a hope that the assessment would provide explanations 
regarding cognitive deficits, with many participants expressing a desire for 
support in coping with their difficulties.  Participants spoke about their desire to 
find answers, to alleviate speculation and empower them with knowledge: 
 
Well I just thought that there was something going wrong in my mind, and I 
wanted my neurologist to refer me to somebody who could explain what 
was going on in my mind. (Wendy:346-349) 
 
I need to understand what was going on. (Arthur:14-15) 
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Some were seeking answers to specific questions, including Lisa who, in light of 
her diagnosis, queried the cause of her forgetting: 
 
I’ve been reading about symptoms of [the neurodegenerative condition], 
and I was asking [the psychologist] “how, how would I, how do you know 
whether it’s a cognitive decline or whether you’ve just got a million things 
on your mind?” (Lisa:74-78) 
 
In this extract, it is clear Lisa made her own attempts to acquire knowledge, but in 
the process, has been left with questions which she hoped the assessment would 
answer.  Others desperately sought strategies to help with their condition: 
 
I’m getting to the stage where I’m getting desperate… you know what’s 
coming, but you’ll do anything to make it go away. (Stephen:635-639) 
 
You can put it into a strategy…then we can start seeing if there’s anything 
we can do which will slow it, slow the [neurodegenerative condition] and 
help me understand what I need to do. (Arthur:76-80) 
 
Arthur’s desire to act and possibly control the progression of his condition is 
palpable.  The use of ‘need’ conveys a sense of urgent requirement, as if he is 
preparing for battle, refusing to give in.  On one hand, Arthur suggests the 
assessment will help him understand the necessary course of action where he 
has previously failed, yet on the other hand, his use of the word ‘if’, nods to the 
fact his search might be futile.   
 
3.4. Relationship with Clinician 
 
This theme captures the importance of the quality of the clinician-patient 
relationship, and the powerful influence this had over participant’s experience.  
For some, the nature of the encounter with clinicians was essential to their 
experience, enabling them to cope with the anxieties of testing, and creating a 
trusting space to discuss difficulties. 
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3.4.1. Positive Clinician Qualities Supported Coping 
Most participants experienced clinicians as friendly, collaborative and person-
centred, allowing them to feel genuinely listened to and put at ease: 
 
I think he was a very good, quite conscientious psychologist…he would 
listen to you, he’d listen to your points of view. (Helen:441-445) 
 
She was quite sympathetic, and she was good with communicating, and 
she made me feel at ease. (Sheila:70-72) 
 
Helen highlights the importance of her views being listened to and heard, 
suggesting she appreciated the collaborative nature of the relationship.  For 
Sheila it was the clinician’s emotional warmth that allowed her to feel at ease.  
Wendy describes her most recent experience as “Rolls Royce”(274), likening her 
experience to a brand known for luxury.  She explains the clinician’s positive 
qualities by comparing her experience with a previous clinician: 
 
I was more patient with him, because he treated me with more openness 
generally, so I felt I could actually accept what he was saying, because I 
felt he listened to me in a very special way. (Wendy:575-583) 
 
Wendy notes the circularity and reciprocity of the relationship, stating how the 
clinician’s behaviours impacted her and vice versa (e.g. the clinician’s openness 
allowed her patience), resulting in her being able to ‘hear’ and accept 
recommendations, rather than feel defensive.  In addition, Wendy states the 
clinician listened in a ‘very special way’, indicating an active listening beyond 
what she had experienced in other relationships.  Graham remarks on the non-
verbal qualities he valued: 
 
[Her] calm clear voice and she smiles, she smiles sometimes [laughter], all 
positive things that you would pick out in a human being’s facial 
expression or whatever, she has them. (Graham:358-362) 
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Most participants identified qualities of the clinician, as helping them cope with 
the emotional demands of assessment: 
 
They tried to keep you at, make you at ease, which is an important factor 
me, because I get a bit uptight otherwise, bit worried. (Jean:173-175) 
 
She was a very calming influence. (Jean:181-182) 
 
For the majority, the clinician’s emotional support seemed to bolster participants 
against more threatening aspects of testing, normalising ‘failure’, reducing anxiety 
and minimising distress.  Jean noted her appreciation for receiving praise from 
the clinician: 
 
Sounds silly cos I’m an adult, but you know, we all need praise sometime. 
(Jean:348-350) 
 
Jean initially dismisses her desire, sensing as an adult she is not expected to 
require praise, before subsequently normalising it.  However, Arthur appears to 
interpret the clinician’s comments as questioning his resilience: 
 
[The clinician] consistently sort of just checked me out say “are you feeling 
okay?”, “are you comfortable?” etc., which is great, but I think I’m resilient 
enough. (Arthur:440-447) 
 
Whilst Arthur verbalises the support as ‘great’, he implies it was not necessary, 
with the use of ‘consistently’ providing a clue that he found it excessive.   
 
3.4.2. Familiarity and Trust 
Many participants described a preference for a familiar clinician, enabling them to 
be aware of participant’s background and fears: 
 
I suppose one of my big fears is that I that I lose some sort of mental 
function, which she’d probably been aware of because I’d spoken to her 
about a number of things…I don’t know whether that particular 
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psychologist was mindful of my concerns, and made a bit of an extra effort 
to explain more. (Lisa:315-321) 
 
Thus, from Lisa’s perspective, familiarity allowed an individualised approach, 
based on her needs.  In addition, familiarity allowed participants to build trust 
prior to the assessment: 
 
I’ve known [the psychologist] a while, so I trust what she says.  Maybe if I’d 
only met her once or twice, or it was [another psychologist]…I might have 
asked a few more questions. (Stephen:421-425) 
 
The good thing was [the psychologist] asking, someone you got to know, 
asking you these questions. If it was a complete stranger asking, you 
would’ve been a bit-, might not of answered them as truthfully or wouldn’t 
have felt as comfortable answering the questions. (Graham:311-319) 
 
The descriptions suggest for Stephen trust is earnt over time, through questioning 
the clinician, perhaps to see if they produce satisfying, trustworthy answers.  
Graham suggests if the clinician was unknown, he would have censored 
answers, preventing a mutual understanding and exchange of information.  It 
seems a strong therapeutic relationship and subsequent trust, reduced anxiety 
and gave participants a sense of ease.  The presence of trust had various 
meanings to participants: 
 
That’s [the feedback] what I wanted to hear, but I knew if it wasn’t, if that 
wasn’t the case, [the psychologist] would have said well “you’re just a 
thicko” [laughter]. (Stephen:440-443) 
 
For Stephen, trust amounted to honesty, implying an unfamiliar clinician may not 
have felt confident breaking bad news, instead protecting his feelings.  However, 
Stephen imitates the news he fears a trustworthy clinician delivering (“you’re just 
a thicko”), perhaps indicating he fears the loss of a previously existing identity in 
which he was cognitively able.  For Graham, trust amounted to the clinician 
having good intentions: 
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I was just glad I found out with someone (.) who was doing it for a good 
reason, rather than someone who would just be trying to take advantage 
of you like, like someone who might be trying to con you or something out 
in the street, and finding out you weren’t so good at something that way 
[laughter], rather than someone just in a friendly atmosphere just pointing 
these things out to you. (Graham:466-475) 
 
Thus, Graham felt reassured the clinician would not exploit possible 
vulnerabilities or wrongly benefit from discovered weaknesses.  In contrast, when 
directly questioned about the possibility of testing with an unfamiliar clinician, Lisa 
stated:  
 
If it’d been another psychologist, that did all the tests, that wouldn’t have 
concerned me, because I’d been briefed quite well about what was going 
to be tested and why. (Lisa:340-343) 
 
Thus, Lisa negates the importance of familiarity, on the basis she had been well 
prepared by a familiar clinician. 
 
3.4.3. Expertise and Power 
Most participants valued the clinician as an expert and “professional”(Helen: 
471), regardless of their status as a qualified or trainee clinical psychologist.  In 
the following extract, Lisa, who was assessed by a trainee, acknowledges the 
significance of the level of training held by the clinician: 
 
Having somebody that’s qualified reading it, obviously makes a massive 
difference, where as I might’ve got the wrong end of the stick or 
something, but there was no chance of that because she was so helpful. 
(Lisa:504-508)  
 
Thus, the clinician’s competence to interpret results, minimised the risk of Lisa 
misinterpreting, which had the potential to impact on her emotional wellbeing.  
Stephen describes the clinician’s actions as ‘wise’: 
Chapter 3: RESULTS 
 
54 
 
 
 [The psychologist] sort of very wisely I think, decided to bring it to an end. 
(Stephen:16-18) 
 
Thus, Stephen suggests the clinician’s capability of good judgement, yet also 
highlights the power held by the clinician to direct the session.  Several other 
participants expressed an awareness for the power held by clinicians.  Wendy 
recalled the clinician had power to influence those who could refer, stating the 
clinician “told my GP to refer me on to a neuro-ophthalmologist” (540-541).  Thus, 
power enabled clinicians to demand and influence behaviour of others.  Following 
these extracts, it is possible to assume there is a power imbalance between 
participants and clinicians, however some participants articulated occasions 
where power was shared between the clinician and participant (further discussed 
in ‘communication of results’). 
 
3.5. Experience During Testing 
 
This theme captures how participants experienced and made sense of testing.  
The absence of feedback during testing, means participants often appraised their 
own performance, resulting in sense of uncertainty, fear, frustration and 
disappointment.  To regulate their emotional response, participants used various 
coping strategies, including focusing on the positive, drawing on previous 
experience, minimising, normalising, avoiding and denial.  In addition, 
participants spoke about the intensity of their experience during testing and the 
importance of the assessment environment. 
 
3.5.1. Subjective Awareness of Performance 
All participants were sensitive to their performance during testing, with some 
recalling a subjective sense of success: 
 
I think I got it exactly right, I was pretty impr-, that’s probably why I 
remember it so well cos I done it so well [laughter]. (Graham:7-10) 
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I was enjoying it, like I said in a perverse way, and I knew, I thought I was 
doing quite well. (Stephen:239-240) 
 
With Graham introducing his sense of success almost immediately in the 
interview, it is clear it was particularly salient.  His commentary and laughter 
suggests the perceived success was unexpected, therefore emotionally 
significant.  Especially within the context of his neurodegenerative condition, in 
which he stands to lose his cognitive ability, his success represented a 
confirmation of retained ability.  Most participant’s accounts were peppered with 
self-doubt, yet Graham asserts his certainty stating he got it ‘exactly right’.  He 
appears to tail off expressing how ‘impressed’ he felt at his performance, perhaps 
not wanting to sound overly self-assured.  Stephen links his enjoyment to his 
perceived skill, although his use of ‘perverse’ acknowledges testing is not what 
most people would expect to enjoy.  He explains:   
 
I got into some dusty corners of my mind actually, it was nice to dust some 
off, yea cos, I’ve had that same job for twelve years and I’m get a bit of a 
routine, so it’s nice to sort of get outside your comfort zone, so I did really 
enjoy it. (Stephen:615-620) 
 
Thus, Stephen felt the testing allowed him to use cognitive abilities he wasn’t able 
to routinely, as if the practice would be beneficial to optimise his abilities.  His 
metaphor of ‘dust’ seems to reflect a cognitive fogginess, with the experience of 
testing indicative of a ‘spring clean’.  Indeed, most participants, relying on their 
subjective appraisal, assumed they had performed poorly (regardless of the 
eventual outcome): 
 
It weren’t sticking in my head, it was that obvious that there was a 
problem. (Graham:21-23) 
 
I realised I’ve still fallen down at things that in the past I wouldn’t have 
found difficult to do. (Wendy:501-503) 
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Thus, perceived ‘failure’, was experienced as highlighting ‘problems’, exposing 
lost abilities.  For participants expecting cognitive decline, confirmation bias may 
have resulted in a tendency to interpret poor performance (rightly or wrongly) as 
confirming deterioration.  Participants appraised their performance based on 
various clues.  Graham notes it was ‘that obvious’, suggesting in his eyes, his 
poor performance felt so apparent it could not be mistaken.  Wendy uses 
comparison to her previous abilities, as measured by daily functioning and 
previous neuropsychological assessment, although her use of ‘still’ implies she 
was already aware of potential decline.  For others, the appraisal of their 
performance was based on intuition: 
 
I knew myself I’d got them wrong, no one had to tell me I’d got them 
wrong. (Jean:80-82) 
 
This suggests, it was not subtle signals given by the clinician, but instead intuition 
that was relied upon for evidence of performance.  Although, as Lisa admits “it’s 
hard to tell when you’re doing the test”(572-573).  Thus, whilst it was clear 
participants endeavoured to make sense of their performance, it was difficult, 
especially whilst testing, to gain an accurate sense of performance.  As Stephen 
vividly captures: 
 
In the middle of all that, you’re sort of thinking, “if I was not-, if I didn’t have 
this diagnosis would I find this difficult or not?” and actually, I’m still not 
quite sure what the answer is because, I think it’s difficult for me, because 
I’m thinking “is that because I’m [this age] or is it because I’ve got [a 
neurodegenerative condition], or could I never have answered that 
question?”, so you’ve got all that going on at the same time. (Stephen:30-
39) 
 
Stephen’s narrative suggests internal rumination simultaneously occurring 
throughout testing, where he questions the cause of his perceived struggling.  
Interestingly, towards the beginning of the extract, Stephen tails off verbalising ‘if 
I was not-’ perhaps suggesting he is hesitant to name the reality of what has 
happened to him.  Stephen continues: 
Chapter 3: RESULTS 
 
57 
 
 
To be honest with you it was a double-edged sword because sometimes I 
was “yes:::” and other times I was “oh s**t I just can’t do it”, and again 
you’re thinking “why is it-, could I ever have done that?” (Stephen:66-70) 
 
Thus, Stephen questions his current performance in relation to his past-self, with 
his use of expletives suggestive of his frustrated emotional state. 
 
3.5.2. Emotional Response to Testing 
With participants seemingly aware of their performance to some degree (albeit 
not necessarily perceived accurately), it follows that participants reported testing 
as an emotionally intense experience, with highlighted inabilities, resulting in 
feelings of loss, fear, stress, frustration, disappointment, self-doubt, low mood 
and low self-esteem: 
 
I was frustrated that I got in a muddle with my memory, my thoughts had 
kind of messed it up. (Jean:54-56) 
 
I got really, really frustrated and I think that showed. (Stephen:11-12) 
 
I was scared that I couldn’t remember things. (Sheila:63-64) 
 
I was going to get stressed about it, cos it’s not-, I’m not st-, handling it 
very well. (Arthur:154-156) 
 
I was a bit disappointed in myself for getting something wrong, cos I 
thought it was quite basic test. (Lisa:185-188)  
 
In these extracts, Stephen’s emphasis of ‘really’ suggests the intensity of his 
frustration, and possible embarrassment the clinician witnessed it.  Arthur 
appears hesitant in naming his difficulty ‘handling’ the test, and was reluctant to 
do so throughout the interview, perhaps to protect his own self-esteem (further 
discussed in ‘coping with testing’).  Lisa finds herself judging the difficulty of the 
test, measuring herself against her own high standard, which she later names as 
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her being a “perfectionist”(604).  Below, Jean highlights her emotional response 
to perceived ‘failure’: 
 
I’ve always beat myself up, in my lifetime, when I don’t feel quite so happy 
about where I am…I’ve always tried to keep up, you know, I mean I wasn’t 
born in a high place in society. (Jean:99-107) 
 
There are several important issues to note in this brief extract.  Jean uses a 
metaphor of physical violence, to show her self-punishing stance towards her 
own ‘failure’ during testing.  This highlights how participant’s histories will 
inevitably affect how they respond to testing.  Jean subsequently points to ‘trying 
to keep up’, implying she felt behind during testing, which she compares, 
unprompted, to her place in society where she too perhaps felt ‘behind’.  Several 
participants described their experience of testing as a series of highs and lows.  
For Jean this reflected her perceived performance: 
 
I felt quite uplifted when I got the questions correct, but I felt quite let down 
when I got them wrong. (Jean:78-80) 
 
Graham shared a similar experience: 
 
When I was getting things right like, I thought “you ain’t that bad, you have-
, there is something that’s still working inside properly”. (Graham:59-62) 
 
[If] I weren’t doing them as well, it did make me “oh what’s wrong with you, 
what’s wrong with you”. (Graham:463-465) 
 
These extracts highlight the turbulent nature of Graham’s emotional reactions, 
alternating from feeling reassured with regards to retaining his faculties, to 
frustrated for ‘failing’ a test he ‘should’ be able to complete.  The use of ‘wrong’, 
suggests he is not only incorrect, but judges and insults himself for the perceived 
‘failure’.  Yet unable to change his performance, he is left to cope with the evoked 
emotions.   
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3.5.3. Coping with Testing 
To cope with demands of testing, many participants utilised a variety of self-
protective coping strategies to alleviate distress.  Participants ability to cope did 
not appear to link directly to their performance, but rather their ability to manage 
the experience, maintaining a positive sense of self.  Stephen spoke about his 
attempt to identify practical strategies: 
 
It’s looking for the key to the puzzle isn’t it, and you find it and you’re okay, 
or finding some way of remembering…once you do that and you’ve got a, 
you’ve found a good way of doing it, you get a bit more confident, 
especially if it’s worked for you, I’ll use that next time I have to do a similar 
question. (Stephen:283-295) 
 
Thus, Stephen uses a ‘key’ metaphor to describe his strategies, suggesting once 
identified, they ‘opened’ his ability, allowing him to build confidence throughout 
testing.  Although, he notes, well-practiced strategies were not always successful, 
hence the process required flexibility, demanding participants to adopt new ways 
of coping.  As well as practical strategies, participants talked about trying to utilise 
strategies to cope with the emotional demands, for instance remaining task-
focused, concentrating on positive aspects of performance and localising areas of 
weakness: 
 
I just thought “alright, them ones you can’t do, but the ones you can do, 
like concentrate on them and make them things better or as good as they 
can be”. (Graham:65-68) 
 
I’d got something wrong, when I say wrong it was one bit. (Lisa:593-595) 
 
Here, Graham urges himself not to dwell on items he found difficult, instead 
encouraging himself to focus his attention and energy on tests he is most likely to 
succeed on.  Lisa emphases the word ‘one’, minimising her perceived ‘failure’, 
later re-framing it as a “minor blip”(442) and “mistake”(447).  Some participants 
normalised negative experiences of testing, for instance Arthur normalised his 
anxiety: 
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Whatever test you’re taking, whatever environment, there’s a level of sort 
of anxiety to it, cos you want to be probably seen to be a good person, you 
want to meet the standard, you don’t want people to talk about you in 
derogatory terms. (Arthur:657-662) 
 
The description suggests Arthur makes sense of his anxiety as stemming from a 
fear of stigma and judgement from others.  Others utilised previous experience, 
both in life and previous neuropsychological assessments, to put the testing in 
perspective: 
 
I realised I’ve still fallen down at things, …that was slightly distressing to 
me, but not really because I’d already experienced that. (Wendy:501-505) 
 
I‘ve had a lot of life in difficult places, so it didn’t stress me at all. 
(Arthur:177-178) 
 
Thus, Wendy had been emotionally prepared for possible ‘failure’ by her previous 
assessment.  In addition, Arthur suggests the testing paled in comparison to 
other life stressors.  Furthermore, he previously talked about his high achieving 
career, during which he completed similar psychometric tests, reducing his fear of 
the assessment.  Arthur approached the testing with a matter-of-fact attitude, 
attempting to resolve potential distress by discontinuing tasks he was ‘failing’: 
 
I tend to take the view on everything, if I can’t do it and I will fail by my 
standard, then it’s better to pull out of it. (Arthur:180-182) 
 
Thus, faced with a threat to self-esteem, Arthur uses avoidance as a way of 
coping.  Although traditionally seen as a less helpful strategy, in this instance it 
allowed Arthur to finish the testing, whilst preserving his capable sense of self.  
Similarly, several participants reported attempting denial, as Sheila admits: 
 
Yea, maybe…I didn’t want to know (.) how bad I was. (Sheila:127-128) 
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On reflection, Sheila acknowledges and articulates possible denial, yet the very 
nature of denial, means it may be possible to interpret from participants accounts 
rather than verbalised directly.  In this extract, Arthur denies the testing was 
challenging: 
 
It was a test…was it a challenging test, not particularly. (Arthur:271-272) 
 
Yet elsewhere in his narrative, Arthur describes the test stresses him to the point 
of halting it, which seems to contradict the idea of the test not being challenging, 
hence denial may be serving to keep the unacceptable reality at bay.  In fact, with 
the potential threat to self-esteem, Arthur appears so enraged as to suggest: 
 
That particular test, I think should be removed, but it’s your call. 
(Arthur:157-159) 
 
Thus, perhaps Arthur not only desires to protect himself, but also others, yet he 
acknowledges the power lies in the hands of the clinician.  In contrast, whilst 
most of the strategies had a beneficial impact on participants ability to cope, 
Stephen acknowledges his attempts to alleviate distress were not always 
successful: 
 
I was very grumpy that day, but I was just struggling, I couldn’t-, I was 
trying to calm myself down and I was just winding myself up. (Stephen:84-
87) 
 
Hence, Stephen, unable to soothe himself and worried he would “give a false 
account”(91) of his abilities, ultimately turns to the clinician for reassurance, 
emphasising the important of the clinician’s role. 
 
3.5.4. Intense and Prolonged 
Most participants spoke about the length of testing and it’s intense and repetitive 
nature: 
 
There’s a lot to get through. (Stephen:531) 
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Some of the things are repetitive, obviously they need to see what you can 
remember. (Sheila:4-6) 
 
It was a two-hour appointment and I was wondering why it was so long. 
(Wendy:12-14) 
 
This experience was common in the interviews and in the case of Sheila and 
Wendy was introduced early in the interview highlighting the prominence of the 
issue.  Whilst Sheila provides a potential reason for the repetitive nature of 
testing, Wendy felt she had not been prepared, and questioned the appointment 
length.  The extracts provide a sense of testing as something to ‘get through’, a 
boring process, to be endured.  Stephen comments he was grateful for the option 
to split testing across numerous sessions.  Stephen highlights the intensity of 
testing compared to other healthcare appointments: 
 
A lot of people come round here to see me from [the service] it’s always 
pleasurable… this was different…we’ve got the clock on, we’ve got a-, you 
can look at these for a minute and then I’ll take them away, so it’s it’s quite 
comp-, you know the-the intense, so that the intensity of a series, an exam 
setting is obviously an intense thing isn’t it. (Stephen:140-153) 
 
Thus, Stephen implies testing was not pleasurable, but intense.  The change in 
pace and flow of his speech seems to reflect the fast-paced and relentless nature 
of the testing, and he ends the passage ‘isn’t it’ perhaps inviting reassurance he 
is not alone.  He later explains how the fast-pace of testing, alongside his internal 
“monologue”(161) and environmental distractions all added to the level of 
intensity.  Helen mirrored this with her description of the time pressure she felt: 
 
There was less time, you know, you answered straight away…you had to 
do like, quite a few different tasks in a set time and see how you coped 
with that. (Helen:162-166) 
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The description suggests Helen experienced a sense of urgency, aware her 
performance would be observed to see how she ‘coped’.  As well as pressure to 
focus, some participants noted the hard work and concentration required: 
 
The tests need some intense thinking in order to crack. (Stephen:167-169) 
 
The use of ‘crack’ implies the tests were problems to be solved, reflecting the 
considerable effort Stephen put in to discover the solution.  Many participants 
commented some tests appeared deceivingly easy, but had a hidden difficulty.  
Several participants spoke of how testing reminded them of being back at school:  
  
At the time, I felt like I was in a classroom, you know like I was at school 
basically. 
I: Tell me more about that. 
That’s how I felt, I felt I was in school, like when I was a child. (Jean:74-78) 
 
Thus, whilst Jean doesn’t explicitly name how she felt as a child, it could be 
interpreted she sensed a loss of control and power of adulthood.  Indeed, 
participants reported it had been a long time since they underwent formal 
examination, hence the testing may be experienced as infantilising, denying them 
of their maturity.  Alternatively, as Jean doesn’t explicitly name feeling like a child 
as undesirable, perhaps she enjoyed relinquishing responsibility of adulthood 
during the testing. 
 
3.5.5. Importance of Environment 
Several participants talked about the importance of the assessment environment 
and its impact on the testing: 
 
I found it difficult to concentrate because there was things going on around 
me and I’m quite a sticky beak, you know what that is, nosey. (Jean:139-
142) 
 
That’s probably the [neurodegenerative condition] where anything can 
distract you, so you know you should be concentrating, but you’re having 
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this sort of monologue…as well as thinking: there’s a spot on the wall, 
there’s a fly; over there’s a pigeon. (Stephen:52-58) 
 
In these extracts, both Jean and Stephen talk about the difficulty of navigating 
environmental distractors, yet interestingly Jean seemingly blames herself for 
being ‘nosey’, whilst Stephen partly blames his condition, hinting at the 
subjectivity of his experienced distractibility.  Perhaps participants sensed they 
‘should’ be able to manage distractors, hence weren’t entitled to an uninterrupted 
environment.  In fact, Stephen goes as far as to suggest it was his responsibility 
to reduce distractors: 
 
Could maybe put the blinds down or something, less distraction, but that’s 
my problem…maybe it was a good environment…but maybe just to give 
thought to the environment, maybe even I could have sat with my back to 
the window, and it would’ve been one slight improvement. (Stephen:803-
814) 
 
Certainly, in hindsight, Stephen had ideas about how to make the environment 
more comfortable.  Another participant appreciated a comfortable, familiar 
environment, with limited distractions: 
 
No issues with regards to where the test was done, or you know, I had 
water and stuff like that, and I knew where the loo was and all that sort of 
stuff, so no absolutely (.) I think the environment was very nice. (Lisa:252-
257) 
 
3.6. Outcome of Assessment 
 
The fourth and final theme captures how participants made sense of varied 
results (with some participants told they had no impairments, whilst others were 
informed of significant deficits).  In addition, this theme will explore the emotional 
impact of results, the future implications, and how meaningful feedback 
empowered participants to cope and adjust. 
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3.6.1. Communication of Results 
The participants spoke about helpful and unhelpful ways in which results were 
communicated.  Prior to the assessment, some participants acknowledged they 
were unaware how cognitive abilities could be affected by their condition, yet 
following feedback, most participants felt they had been provided with a thorough 
explanation: 
 
She had all print outs and they explained with very simple 
diagrams…colour coded, and she made it simple so you could 
understand, and she explained it and left the folder with me. (Sheila:327-
331) 
 
She sort of briefed me at top-level say, you know, cos I’m not a 
psychologist, or medic, so she just sort of went through what it was, that 
was being…tested, and why. (Lisa:299-303) 
 
Thus, Sheila appreciated the comprehensible and diagrammatic feedback, which 
she could revisit as necessary, empowering her.  Lisa notes the explanation was 
‘top-level’, suggesting she felt provided with the highest level of explanation, 
although she mentions she is not a professional, emphasising the importance of 
an explanation appropriate to participant’s level, without jargon.  As Stephen 
recommends: 
 
It’s worth bearing in mind that people suffering from my symptoms are 
sometimes not the sharpest tools in the toolbox, or not as sharp as they 
used to be, so an overall brief of what’s gonna happen, what’s happening, 
what’s happened. There’s an old saying – tell them what you’re gonna tell 
them, tell them, tell them what you’ve told them, you can’t go wrong with 
that. (Stephen:708-715) 
 
Hence, repetition and clear explanations enhanced participant’s ability to 
understand, minimising the potential for participants to feel ‘stupid’.  Wendy notes 
the clinician made feedback “comprehensible”(575); hence she attributes her 
ability to comprehend, to the clinician’s skill, who empowered her to understand.  
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Arthur picked up the clinician’s hesitancy explaining results, leading him to 
question whether the clinician was “buying time”(592) to tell him bad news: 
 
[The clinician] was, I felt, very cautious about what she was going to say, 
and I felt, you know, is there something you don’t want to tell me…if there 
is something you need to tell me, that’s going to be unpleasant…just tell 
me, I can get on with my life. (Arthur:400-410) 
 
Arthur seems to say that the clinician may have been attempting to break bad 
news gently, to prevent him entering a “crisis”(623), but he desired directness 
and honesty.  Participants emphasised the value of written feedback, with 
separate versions for themselves and professionals.  As Helen explains: 
 
He wrote it up and sent me a copy of that, but that was more from a 
clinical point of view, so he then wrote it out in a layman’s point of view 
[laughter] for me to be able to follow. (Helen:75-79) 
 
Helen’s laughter potentially conceals her embarrassment regarding her difficulty 
understanding the ‘clinical report’, as she later explains “I’ll be sitting there with 
the dictionary all night”(454-455).  Wendy also reported difficulty understanding 
the report remarking “these things are a bit technical”(407-408).  However, for 
Helen, the clinician subsequently provided a report appropriate to her level, 
ensuring Helen fully understood, providing her power and control.  Participants 
appreciated the opportunity to involve their family during feedback: 
 
He invited my family and…went through the results again with them. 
(Helen:112-113) 
 
Although as Sheila notes it was important the decision was hers: 
 
It’s confidential, so it was fed back to me and then I could tell, if I wanted 
to. (Sheila:402-403) 
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Thus, Sheila was empowered to be involved in deciding how and if feedback was 
shared.  As well as feedback, some participants appreciated being signposted to 
relevant support: 
 
I was given a lot of information about (..) [the neurodegenerative condition] 
and organisations, and who can help like, so they were, not just giving me 
feedback on how I was doing, but with other groups that can help. 
(Sheila:257-262) 
 
Sheila’s use of ‘just’ suggests she experienced this as the clinician going beyond 
the basics of simply providing feedback.  Unfortunately, one participant was 
unable to recall receiving any feedback at all.  Of the remaining participants, Lisa 
reported the feedback was “pretty prompt”(496), but unfortunately for Arthur 
waiting for feedback exacerbated frustrations: 
 
What the tests did was excite curiosity, but then to have to wait for three 
weeks and then wh-, there’s three months of my life left [inaudible- 
16:04:08], I can’t understand. (Arthur:320-324) 
 
Thus, the frustration Arthur felt at an unexplained delay, was intensified in the 
context of his limited life expectancy.  Furthermore, he explains, the testing 
“created some impetus, some momentum”(364-365) and that: 
 
It becomes less relevant, I mean the longer you leave it between two 
events, then the less effective it is, cos if someone says to you “by the way 
do you remember sixteen weeks ago we did this” and I say “no”. 
(Arthur:713-717) 
 
Hence, for Arthur, difficulties with his memory also became a barrier to effective 
feedback, highlighting the significance of timely feedback. 
 
3.6.2. Meaning of Results 
Participants made sense of the results in a range of ways.  Many participants 
spoke about results as ‘proof’ of their own sanity: 
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It’s helpful for my confidence to know that I haven’t lost my marbles 
completely. (Stephen:371-373) 
 
I: Can you tell me which bits you found most helpful? 
Well knowing I haven’t got onset of Alzheimer’s, knowing I’m not crazy. 
(Sheila:342-345) 
 
Thus, results provided participants reassurance of their rationality, removing the 
concern about dementia.  As Graham vividly captures, the results confirmed he 
wasn’t ‘damaged’:  
 
I’m not as damaged mentally as I am physically [laughter]. It’s made me 
realise that…there don’t seem to be as much damaged in the nerves in me 
brain, that have stopped me from being the same person mentally as I 
always have been. (Graham:417-420) 
 
Thus, for Graham, the results demonstrated he had retained his self-identity, 
value and personhood.  In contrast, many participants spoke about results as a 
verification of genuine illness.  For Helen, receiving “proof”(213) of her condition, 
allowed her to externalise difficulties: 
 
It’s because I’ve got [a neurodegenerative condition] that I’m slow. 
(Helen:283-284) 
 
Whereas, the reverse was true for participants receiving results confirming no 
impairment: 
 
It made me realise that actually, you can’t blame [the neurodegenerative 
condition] for everything, you know the reason that you’ve got odd socks 
on is because you’ve got a hangover and you’re scatty. (Lisa:681-685) 
 
Chapter 3: RESULTS 
 
69 
 
Thus, Lisa, unable to blame her condition, appears to normalise difficulties, 
blaming ordinary absent-mindedness.  For Stephen, the results were particularly 
meaningful because of the objective nature of the assessment: 
 
You’re never the best place to judge yourself are you so, people are polite 
you know, they’re not gonna say “that’s wrong”, or “your mind’s wondered 
a bit” or “what you talking about”, so to get an affirmation that actually from 
the outside your cognitive powers are pretty good, that’s quite good right. 
(Stephen:491-499) 
 
I found it comforting that it was as challenging as it was. 
I:  You found that comforting? 
Yea, yea, you know cos it could have been like you “put these square 
blocks in the round hole” sort of [both laugh], you know if it was patronising 
I’d be disappointed, annoyed.  So I felt like I’d had a rigorous brain teasing 
test. That was important, to feel like I [inaudible- 20:39:27] had been sort 
of challenged. (Stephen:390-399) 
 
In these extracts, Stephen explains that (unlike his peers, who could not be relied 
upon to provide candid appraisals), the assessment bypassed ‘politeness’, 
providing an honest evaluation of his cognitive abilities.  Despite the possibility of 
evoking feelings of ‘failure’, Stephen valued the challenging nature of the 
assessment as it demonstrated he wasn’t being patronised, hence could trust the 
outcome.   
 
3.6.3. Emotional Impact of Results 
Participants found receiving results an emotional experience, and for the majority, 
their responses were influenced by the outcome received, especially if it was 
unexpected.  Comparable to the experience reported during testing, participants 
reported difficult emotions in response to confirmed weaknesses: 
 
The only unhelpful thing was, finding out that things that you were bad at, 
and feeling a bit low initially. (Graham:458-460) 
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Thus, Graham, exposed to evidence of his weaknesses, felt saddened, perhaps 
‘grieving’ a lost ability.  As Helen remarks: 
 
It’s difficult because you have to become aware of the fact that yo-you’re, 
you’re actually dying. (Helen:495-497) 
 
Hesitant to name the reality, Helen highlights how results can act as a stark 
reminder of participant’s fate.  Graham reveals how this scared him: 
 
I’ve always tried to concentrate on the things that I can do, and when this 
test brought up the things that I couldn’t do…it did sort of scare me…it 
made me face what-, it put down in black and white in real terms factual 
way, what I can’t do, and I’ve spent the last twenty years avoiding that. 
(Graham:256-264) 
 
Thus, Graham describes receiving results as somewhat confronting, especially 
their formal nature which increased their permanence and factuality.  It appears 
results forced participants to face the reality of their conditions; they could no 
longer use ways of coping, such as avoidance and denial, leaving participants 
vulnerable to emotional distress.  In contrast, participants whose results showed 
no cognitive deficits were reassured and lifted in mood.  As Lisa explains: 
 
It was quite handy to know that I didn’t need to worry about that 
component of my condition. (Lisa:670-672) 
 
Hence, the results gave Lisa permission to put concerns to the back of her mind.  
Similarly, most participants reported a positive emotional impact: 
 
A relief, it’s like a curtain lifting. (Sheila:299) 
 
It was a real boost of my confidence, it was a bit of sunshine on a bit of a 
gloomy horizon all round. (Stephen:623-625) 
 
Chapter 3: RESULTS 
 
71 
 
Metaphoric language was common in the interviews, with Sheila, comparing 
results to a ‘curtain lifting’, suggests she felt an insurmountable weight had been 
lifted and she could ‘see the light’ after prolonged turmoil.  For Stephen, his 
comparison to weather indicated the results bought positivity in to an otherwise 
foreboding future, by reaffirming his cognitive ability and resolving his self-doubt.  
Perhaps the ‘gloomy horizon’ is symbolic of Stephen, in the ‘winter’ of his life, 
making him more grateful for sunshine (positive results).  For Graham, the 
positive results and new coping strategies had a huge therapeutic impact: 
 
I’ve been quite depressed, but working out that thing, that was a positive 
thing, that was the most positive thing that’s come out of the last two years 
really. (Graham:48-51) 
 
To put the enormity of this into context, when talking about both his 
neurodegenerative condition and depression, Graham became tearful and later 
explained: 
 
It sounds a bit extreme, but you think like, part of you has sort of died. 
(Graham:531-532) 
 
Thus, for Graham the results represented an antidote to his grief at losing part of 
himself, by reconnecting him to his previous self-identity.  Regardless of 
outcome, participants reported the process as positive and helpful.  Certainly, 
participants felt it was meaningful to share results with their families: 
 
I:  Were the results meaningful for the family, or- 
I don’t know about them, but I felt better that I had an explanation to them. 
(Sheila:387-390) 
 
It was putting in, um, (…) er, making, um, you know your family aware of 
what they were gonna have to experience. (Helen:24-26) 
 
For the sake of my wife and my kids, they need to, they too need to 
understand what’s going on. (Arthur:688-690) 
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For Sheila, the results empowered her with an explanation of her ‘hidden’ 
disability, whereas for Helen and Arthur, the results provided a tool to increase 
their family’s knowledge of their conditions.  The hesitant nature of Helen’s 
extract mirrors her difficulty in broaching this topic, hence results may potentially 
enable a very difficult conversation for Helen and her family regarding the reality 
of her condition going forward.  Arthur’s emphasis on ‘too’ highlights the 
importance of the family’s involvement, perhaps in preparation for when he will no 
longer understand ‘what’s going on’.  For many, relief was shared with family 
members: 
 
[The results] gave the family some confidence, you know cos they see me 
struggling a bit more each week, so for me to be able to say “well 
cognitively I’m all there”. (Stephen:554-557) 
 
Thus, despite evidence of decline, Stephen was able to reassure his family to a 
degree not possible before, as if the results corroborate his assurances.   
 
3.6.4. Coping Strategies Provided Power and Control 
Participants spoke about acquiring useful strategies from the assessment, 
supporting them to accommodate their deficit and modify their approach to tasks: 
 
[The psychologist] was putting forward ideas…ways which you could 
compensate for those problems …to help make your life easier. (Helen:42-
49) 
 
I do feel better afterwards when it’s pointed out in these ways, a way that 
you can sort of deal or cope with it. (Graham:276-278) 
 
Thus, feedback seemingly facilitated future coping, or as Helen states it helps 
find “solutions”(16) to ‘fix’ her problems.  As well as seeking solutions, 
participants spoke about coping strategies encouraging a process of adjustment 
and acceptance: 
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I just gotta sort of accept that there are weaknesses there. (Graham:91-
92) 
 
It’s coming to terms with it…knowing your weaknesses. (Helen:554-555) 
 
For others, the possibility of regaining some control over the impact of their 
condition proved motivating: 
 
 At some points I’ve just thought “things are just gonna go downhill, there’s 
nothing you can do about it mate”, but when I saw that [feedback], I 
thought “well there is something you can do to help, to slow thing down”. 
(Graham:37-41) 
 
Thus, for Graham, on the verge of giving up, the coping strategies provided a 
sense of control in contrast to previous pessimism regarding perceived inevitable 
decline.  As Helen optimistically notes: 
 
There’s always a way of doing things, it might not be the way you normally 
do it, but there’s always other ways. (Helen:194-196) 
 
This extract suggests coping strategies empowered Helen, leaving her with a 
sense of positivity.  Other participants also spoke about the empowering nature of 
feedback: 
 
Quite often you’ll get asked in, when you go to hospital appointments, to 
relay your symptoms, or what not, so it was good for me to understand 
that I didn’t have those symptoms. (Lisa:649-653) 
 
If you’ve got knowledge of what’s going on, it takes away the fear, I think, 
of things when they go drastically wrong. (Helen:227-229) 
 
Thus, participants gained knowledge from feedback, which they applied to 
personally meaningful situations.  For Lisa, it supported her in navigating 
healthcare appointment, whereas for Helen it helped her manage when things 
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didn’t go to plan.  Participants who did not receive meaningful feedback on how 
to cope with difficulties felt sorely let down, or as Wendy describes 
“heartbroken”(310): 
 
The only thing that upset me was I was not being offered any assistance 
with how to deal with this, and I thought “there must be techniques that I 
could learn”. (Wendy:517-520) 
 
3.6.5. Future Implications 
For some participants, the feedback was a valuable tool, helping them prepare 
for future cognitive decline or consider implications for their occupational role: 
 
I found it useful, because I’m still working, to maybe make me think “you 
might want to just review when you do something at work, to make sure 
that you have got the ordering correct”. (Lisa:23-27) 
 
There’s times I think, “oh yes I could do that, I could do a job” and realise I 
can’t do a nine to five job, because I can’t handle the pressure, the speed, 
I can do maybe those jobs, but far less of them, and at much longer time. 
(Helen:315-320) 
 
For Lisa, the feedback, despite indicating no significant impairments, introduced 
self-doubt over her work performance, resulting in her making adjustments.  For 
Helen, the results highlighted difficulties she would face in a work environment, 
perhaps triggering a realisation of her potential lost societal value.  In the 
following extract, it is clear feedback has made Helen consider how her role 
within her own family will change: 
 
As the years go on I do less and less work [both laugh] and they do more 
and more for me. (Helen:379-381) 
 
This is clearly significant for Helen, as she later jokes about feeling a 
“burden”(462).  Whilst this shift in generational roles in a family’s life cycle (Carter 
& McGoldrick, 2005) is conventional in western culture, for Helen the feedback 
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highlights it may be happening sooner than expected.  Although feedback was 
experienced overwhelmingly positively, Stephen questions its future usefulness: 
  
You know where you stand there, until the next set of tests. (Stephen:499-
500) 
 
Thus, Stephen acknowledges the results are only valid until the next set, 
highlighting the assessments inability to provide certainty over the future 
progression of his condition.
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4. DISCUSSION 
 
 
4.1. Overview 
 
In this chapter the themes from analysis will be summarised and discussed in 
relation to the original research questions, revisiting previous literature to provide 
context.  I will then reflect on the research process and outcomes, considering 
clinical implications, before discussing methodological considerations and 
directions for future research. 
 
4.2. Brief Summary of Analysis 
 
The analysis generated four superordinate themes: expectations of assessment, 
relationship with clinician, experience during testing and outcome of assessment.  
Overall, the experience of neuropsychological assessment was emotion evoking, 
with participants endeavouring to cope with, and make sense of the experience 
throughout.  Whilst individual experiences varied, and although participants 
reported negative aspects of testing, most talked about the process as a positive 
experience.  In deciding to undergo assessment, participants appeared to weigh 
up their own and other’s desire for understanding, against the potential for 
negative outcomes.  In terms of the rationale for assessment, participants hoped 
it would provide objective evidence of suspected or ‘hidden’ cognitive deficits, and 
provide a measure of their condition’s progression, an increased understanding 
and help to cope with potential impairments.  Participants had mixed views as to 
whether assessment was mainly for their own benefit or a powerful tool utilised 
by clinicians to gather information. 
 
Participants said that the relationship with the assessing clinician was vital in 
determining their experience and helping them to withstand the emotional 
stresses of testing.  Participants appreciated the emotional warmth and 
collaborative nature of the clinician, and valued feeling genuinely listened to and 
heard, whilst also respecting the clinician’s expertise and power to influence.  
Familiarity with the clinician was talked about as preferable as it generated 
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feelings of trust and improved mutual understanding.  Feelings of uncertainty 
were voiced regarding unfamiliar clinicians, although these could be lessened if 
the participant felt they had been otherwise well-prepared for the process. 
 
Participants spoke about diverse experiences during the testing; on one hand 
enjoying the challenge and sense of retained ability, whilst at other times 
questioning their ability and sensing poor performance, the latter resulting in 
feelings of frustration, stress, fear and disappointment.  To cope, participants 
used an array of strategies: focusing on the positive, normalising anxiety, 
minimising ‘failure’, and denying the test’s difficulty, in order to complete the test 
whilst maintaining a positive sense of self.  Participants viewed the testing as 
prolonged, intense, fast-paced and hard work, with some drawing comparisons to 
being back at school.  The assessment environment was highlighted as 
important, with distractors felt to negatively impact performance. 
 
There was an overall sense the assessment provided objective ‘proof’ of the 
presence or absence of cognitive deficits.  Participants expressed the view that 
the feedback empowered them, providing an explanation and understanding of 
any deficits, and resulting in coping strategies to adjust and retain control over 
areas of difficulty.  Participants valued written and accessible feedback, and the 
option to involve family members in the feedback process, to help increase 
relative’s awareness of their condition.  Negative experiences predominantly 
related to the absence of suggested coping strategies and feedback that was 
delayed or communicated in a way that was experienced as technical.  
Participants described mixed responses to feedback; positive feedback had a 
therapeutic impact, reconfirming participant’s self-identity and providing a sense 
of relief and confidence, whereas feedback confirming deficits had the potential to 
be confronting, with participants forced to face the objective description of their 
condition. 
 
In conclusion, the analysis suggests that the process of neuropsychological 
assessment was experienced as intense and fraught with potential emotional 
challenges, including the possibility of being exposed to evidence of lost 
functioning.  Yet, despite this, most emerged with a sense of having benefitted 
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from the experience, grateful for confirmation of retained abilities or strategies to 
cope with impairments.  The issues raised by the analysis have significant 
implications for clinical and ethical practice. 
 
4.3. Consideration of Findings in Relation to Research Questions 
 
4.3.1. What Do People with A Neurodegenerative Condition Say About Their 
Experience of Neuropsychological Assessment, and How Do They Describe 
This?  
In this section, the first two research questions will be considered together.  
Elements of participant’s experience that were considered helpful or unhelpful will 
be discussed in section 4.3.4. 
 
4.3.1.1. Deciding to undergo the assessment: Participants described an internal 
struggle to balance the desire to undergo assessment, with the fear of potential 
unwanted outcomes.  Despite apprehension, participants sensed assessment 
was the ‘right’ thing to do and would help them and others, hence they possibly 
felt obligated to continue.  Unfortunately, literature exploring client’s decision 
whether to undergo assessment is non-existent.  Participants implied an external 
encouragement to undergo assessment, perhaps from family members or 
professionals.  This is similar to findings by Blake (2004) and Owen (2012) 
suggesting neuropsychological assessment was comparable to other medical 
procedures participants were ‘told’ to undergo, with participants generally happy 
to oblige a trusted professional, almost unquestionably, even when they were 
without a clear rationale as to why.  Blake (2004) noted ‘coerced’ assessments 
usually resulted in more threatening and less satisfactory experiences, 
highlighting it is preferable for clients to have an independent desire to undergo 
assessment. 
 
4.3.1.2. Subjective awareness of performance: Participants reported a subjective 
awareness of their own performance during testing, at times sensing success, 
whilst at other times perceiving ‘failure’ when participants sensed they performed 
poorly, faced with tasks they found difficult or impossible.  This is consistent with 
findings of Keady & Gilliard (2002) who described participants as adopting a self-
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evaluative stance towards their own performance, and Krohne et al., (2011) who 
described participants who felt the burden of developing their own interpretations. 
 
4.3.1.3. Coping with testing: Participants described using self-protective coping 
strategies to alleviate distress and maintain a positive sense of self throughout 
testing, ranging from remaining task-focused and focussing on the positive, to 
normalising ‘failure’, discontinuing tasks and recalling previous experiences to 
help put testing in perspective.  Similar use of strategies has been reported in 
previous studies, including Owen’s (2012) study where participants described 
switching off and remaining positive, Conniff’s (2008) study where children 
reported using distraction, humour, concentration to focus on tasks, and Keady & 
Gilliard’s (2002) study where older adults with suspected dementia relied on 
others for clarification and used ‘strategic resistance’ and ‘making excuses’ to buy 
themselves more time to figure out what was happening. 
 
4.3.1.4. Importance of environment: Participants expressed the importance of the 
assessment environment, describing how distractors were problematic for their 
ability to concentrate, hence impacting their performance.  Other than the 
significant negative impact of distractors, for which participants often blamed 
themselves, participants otherwise reported satisfaction with the assessment 
environment, similar to findings by Bennett-Levy et al. (1994), but dissimilar to 
studies where participants commented on problems with room size and 
temperature (Keady & Gilliard, 2002; Owen, 2012; Westervelt et al., 2007), lack 
of waiting rooms (Foran et al., 2016) or the room being unfriendly and 
medicalised with “pictures of brains…on the walls” perpetuating anxiety (Keady & 
Gilliard, 2002, p.17).   
 
4.3.1.5. Meaning of results: Overall participants reported gaining feedback that 
was meaningful.  Some participants talked about the results as proof of retained 
ability and sanity, while some felt results provided proof of their condition and 
objective evidence of suspected cognitive decline.  Participants receiving 
confirmation of cognitive ability spoke of feeling reassured, retaining their self-
identity and value, as if the possibility of cognitive decline had undermined their 
personhood, as Kitwood (1997) described in people with dementia.  Participants 
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receiving confirmation of impairments, spoke of feeling the impact of their 
condition had been validated and legitimised, especially as cognitive decline had 
otherwise felt ‘hidden’ compared to physical aspects.  Vast amounts of the 
literature support this, with participants reporting the importance of validation 
(Bennett-Levy et al., 1994; Blake, 2004), even if the results were merely a 
confirmation (Westervelt et al., 2007), and participants with TBI reporting the 
results were proof they were ‘not making it up’ (Nochi, 1998), resulting in relief of 
understanding difficulties (Owen, 2012). 
 
4.3.1.6. Future implications: Participants talked about the assessment causing 
them to question and adjust occupational and family roles, highlighting potential 
accelerations to participant’s family life cycle (Carter & McGoldrick, 2005), 
although as Rosado et al. (2017) noted feedback improved participant’s ability to 
cope with transitioning out of work roles and turn responsibility over to other 
individuals.  In Conniff’s (2008) study, implications were also described by 
children who noted the social implications of having to move groups at school 
following the assessment.  Participants also questioned the future usefulness of 
the assessment in the face of an ever-changing and progressive condition. 
 
4.3.2. How Did the Experience Make Them Feel? 
4.3.2.1. Emotional response to testing: Participants described a range of 
emotional responses to testing, which in the absence of feedback, tended to be 
based on participants own appraisal of their performance.  Enjoyment following 
perceived success, was replaced with feelings of frustration, disappointment and 
self-doubt, when participants sensed they performed poorly, leading them to 
subsequently question their ability.  Participants experienced perceived ‘failure’ as 
highlighting possible cognitive decline, threatening participant’s sense of self, 
especially on tests they felt were ‘basic’ or would previously have been within 
their sphere of competence.  The range of emotions reported including pleasure, 
frustration, anxiety, nervousness, confusion; which are similar to those captured 
by other studies, (Bennett-Levy et al., 1994; Conniff, 2008; Keady & Gilliard, 
2002; Owen, 2012).   
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Whilst perceived performance had an immense impact on how participants felt, 
emotional responses were also influenced by participants own histories.  For 
instance, participants who mentioned histories of depression, perfectionism or 
being overly critical, reported being susceptible to feeling low and disappointed.  
Feelings of self-doubt seemed particularly widespread, as participants, in 
response to their diagnosis of a neurodegenerative condition, talked about 
constantly doubting the presence of their own abilities.  Overall, although testing 
evoked mostly negative emotional responses, participants said that the testing 
needed to be challenging to provide beneficial outcomes (e.g. objective 
evidence).  Although prepared for the practical elements of assessment, 
participants did not appear to feel prepared for the emotional reality of 
assessment. 
 
4.3.2.2. Emotional impact of results:  To some degree, this mirrored the emotional 
response participants reported during testing, in that a confirmation of cognitive 
deficits resulted in difficult emotions, as participants were confronted with 
evidence of cognitive weakness, and the subsequent impact on self-identity 
(Krohne et al., 2011).  This is similar to previous studies that noted repeated 
‘failure’ can strengthen feelings of incompetency (Cheston & Bender, 2005) and 
depression (Bennett-Levy et al., 1994) and negatively reinforce the impact of the 
condition (Owen, 2012).  However, for participants receiving reassurance of 
retained ability, there was a therapeutic shift towards feeling emotionally 
optimistic.  Participants described feeling a huge sense of relief (shared with their 
family), their confidence and self-identity positively boosted, consistent with 
previous findings where participants responses were influenced by outcome of 
the assessment (Robinson, 2016).  In the current study the emotional impact was 
not only influenced by the outcome of the assessment, but also how participants 
made sense of the results and the style of the feedback.  For instance, some 
participants, despite scoring poorly, reported a positive emotional impact as the 
assessment verified their condition and provided ways to cope with deficits.  
While for many, the testing itself was filled with emotional turmoil, most 
participants felt that through the process they had achieved a meaningful and 
worthwhile outcome. 
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4.3.3. What Was Their Understanding of Why They Were Assessed? 
4.3.3.1. To measure cognitive decline: Participants reported that the assessment 
was to discover potential cognitive deficits, to find out how much their cognitive 
abilities had been impacted, and to measure progression of their condition.  
Some participants presented a more limited understanding of the assessment as 
a tool utilised by professionals to discover problems in order to determine ways to 
help.  Overall, participants talked about having a satisfactory understanding, 
reflecting what they had previously been told by their clinician or based on their 
own personal understandings if the rationale was not made clear (Keady & 
Gilliard, 2002).  With a reported relationship between degree of preparation and 
overall experience of the assessment (Bennett-Levy et al., 1994), the level of 
preparation experienced by participants in this study may link to participants 
reported satisfaction with the experience.  Previous studies found patients were 
poorly prepared, such as Blake’s (2004) doctoral thesis where one participant 
reported “nobody told me anything about it”, or as in the study by Bennett-Levy et 
al., (1994) where only half of participants felt adequately prepared for the 
assessment.  Hence the shift in ‘preparedness’ may have resulted from 
implementation of policy recommendations to improve pre-assessment 
preparation (Foran et al., 2016; Owen, 2012).  That said, participants did not 
report on whether they were told more specifically what to expect from being 
tested. 
 
4.3.3.2. Anticipating understanding and coping advice: Participants approached 
the assessment with a desire for explanations and coping strategies to help them 
understand and manage impairments.  This was an unmistakable and shared 
request to emerge from interviews, highlighting participant’s strong need to find 
meaningful solutions to everyday problems and maintain a sense of control over 
their cognitive ability.  Hence, this study suggests people with neurodegenerative 
conditions hold the same desire for information as patients experiencing other 
chronic health conditions (Meredith et al., 1996; Nease & Brook, 1995).  This 
contrasts with hypotheses suggesting clients may choose to limit their 
understanding to emotionally protect themselves (Owen, 2012).  The desire for 
strategies is highly similar to findings by Blake (2004), but appeared in contrast to 
the study by Bennett-Levy et al. (1994) which found only 50% were aware the 
Chapter 4: DISCUSSION 
83 
 
assessment could help them ‘get around’ problem areas in their life.  This 
difference could reflect that whilst clients have always desired information, a lack 
of preparation for assessment left them unaware of the possibility of gaining 
practical strategies until recently.  As awareness increases, perhaps clients are 
feeling empowered to request this as an outcome (Ocloo & Matthews, 2016). 
 
4.3.4. What Do They Find Helpful or Unhelpful About the Process? 
The main findings covering helpful aspects seemed to relate to participant’s 
relationship with the clinician.  The assessment feeling intense and prolonged 
was considered an unhelpful aspect of the assessment.  The findings relating to 
‘communication of results’ and ‘coping strategies providing power and control’ 
highlighted both helpful and unhelpful aspects of the process. 
 
4.3.4.1. Positive clinician qualities supported coping: Participants indicated the 
clinician-patient relationship as key in facilitating the assessment process and 
ability to cope with the emotional demands of testing, with good therapeutic 
rapport reported as potentially improving uptake of recommendations.  This is 
consistent with various studies reporting participants valued the clinician’s 
respect and listening skills (Owen, 2012), organisational skills (Foran et al., 
2016), awareness of the person’s context and the person as an individual (Blake, 
2004; Lee, 2012), and taking time to explain the process and feedback (Foran et 
al., 2016; Owen, 2012: Westervelt et al., 2007).  Certainly, in both current and 
previous studies, lack of therapeutic rapport was a lead contributing factor for 
participants reporting negative experiences (Blake, 2004; Owen, 2012).  The 
findings support the claim that therapeutic alliance is an essential foundation, and 
significantly impacts on therapeutic and healthcare outcomes (Kelley, Kraft-Todd, 
Schapira, Kossowsky & Riess, 2014; Martin, Garske & David, 2000) and 
enhances engagement and outcome of testing (Prigatano, 2000).  However, 
there is some disparity with Robinson’s (2016) study, where participants 
experienced the clinician as occupying two opposing roles: as person-centred 
during clinical interview but didactic and task-focused during testing.  
Furthermore Bennett-Levy et al., (1994) suggest it may be ‘the system’, including 
the service, which has a more powerful impact on participant’s experience rather 
than the individual clinicians. 
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4.3.4.2. Familiarity and trust: Participants described preferring familiar clinicians, 
with whom they had good therapeutic rapport, and therefore trusted to provide 
objective answers.  They said that familiar clinicians created a safe space, 
allowing openness and vulnerability, improving mutual understanding.  For 
participants known to clinicians, the assessor was aware of participant’s histories, 
allowing them to recognise individual qualities, provide individual reassurances 
and potentially increase adherence to recommendations.  Previous studies 
similarly advocate for a good relationship with the assessing clinician prior to 
assessment (Keady & Gilliard, 2002; Owen: 2012) which has been suggested to 
improve overall satisfaction with the process (Foran et al., 2016).  Feelings of 
uncertainty and anxiety were voiced regarding the idea of an unfamiliar clinician, 
as in previous studies where the lack of familiarity of new professionals increased 
anxiety prior to assessment (Conniff, 2008; Owen, 2012).  An unfamiliar clinician 
did not necessarily result in a negative experience, especially if the participants 
had been well-prepared by a familiar clinician, although as Owen (2012) notes 
unfamiliar clinicians had to work hard to establish a relaxed atmosphere and build 
rapport to reduce anticipatory anxiety. 
 
4.3.4.3. Expertise and power: Participants described appreciating clinician’s 
expertise, regardless of their level of training.  This is consistent with several 
studies which highlight that establishing rapport is more essential than the 
clinician’s qualification level (Bennett-Levy et al., 1994; Blake, 2004; Donofrio et 
al., 1999; Westervelt et al., 2007).  The only exception is noted by Owen (2012) 
where a participant reported strong negative feelings regarding the perceived 
lack of qualifications by the assessor.  Participants described appreciating the 
power held by clinicians, especially when it was used to help achieve a desired 
outcome.  Whilst appreciating clinician’s power, participants also appreciated 
instances when power was lessened, such as clinicians providing understandable 
feedback.  Previous studies suggest participants accepted a relatively powerless, 
passive role during assessment (Conniff, 2008; Owen, 2012). 
 
4.3.4.4. Communication of results: Participants talked about valuing feedback 
that was comprehensible, written and pitched at an appropriate level, in line with 
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the BPS’s (2002) Code of Good Practice for Psychological Testing which states 
feedback should be clear and appropriate to client’s level of understanding.  
Participants commented that sharing feedback with their family was a way to 
communicate difficulties, similar to findings by Blake (2004) who suggested it also 
reinforced advice regarding coping strategies.  Negative experiences 
predominantly related to delayed or inaccessible feedback, reducing the potential 
to facilitate learning, with similar findings previously reported, including difficulty 
understanding or remembering feedback (Bennett-Levy et al., 1994; Foran et al., 
2016), client’s feeling disempowered by unexplained terms (Owen, 2012), and 
distress exacerbated by waiting for feedback (Robinson, 2016).  In contrast, 
Blake (2004) found participants did not report concern over delayed feedback if 
they had been informed of likely timescales.  One participant reported the 
clinician appeared hesitant to deliver negative feedback, which bore similarities to 
findings by Blake (2004) who hypothesised clinicians may be avoiding 
challenging therapeutic responsibilities, especially in contexts where they feel 
overstretched, despite studies suggesting it is not in the best interest of the client. 
 
4.3.4.5. Coping strategies provided power and control: Participants reported 
feeling empowered by feedback that facilitated coping and enabled them to retain 
a sense of self as capable and in control, mirroring experiences of those with 
suspected dementia (Robinson, 2016).  This builds upon previous studies where 
participants reported feedback and recommendations as helpful (Donofrio et al., 
1999; Westervelt et al., 2007), especially understanding the application of results 
to everyday life, including practical advice on coping strategies to help get around 
problem areas (Bennett-Levy et al., 1994; Blake, 2004), to improve daily 
functioning (Owen, 2012) and increase quality of life (Rosado et al., 2017).  As 
Bennett-Levy et al. (1994) stated, the usefulness of feedback was key in 
determining participant’s experience of assessment.  Participants spoke of 
strategies triggering a process of adjustment and acceptance, similar to previous 
studies, with new knowledge providing power (Foucalt & Gordon, 1980) and 
aiding self-acceptance (Conniff, 2008; Owen, 2012).  As Blake (2004) explains, 
the assessment, with a “high degree of threat…to the person’s sense of cognitive 
integrity, can provide opportunities for significant learning” (p.101).  Participants 
who reported a lack of suggested strategies, described feeling unsupported, 
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highlighting the importance of providing meaningful feedback including potential 
strategies. 
 
4.3.4.6. Intense and prolonged: Participants described the testing as intense, 
lengthy, repetitive, fast-paced and hard work, comparable to descriptions in other 
studies of the testing as relentless, time-consuming, difficult and exhausting 
(Bennett-Levy et al., 1994; Conniff, 2008; Foran et al., 2016; Westervelt et al., 
2007).  Participants spoke about feeling pressurised due to timed aspects, 
resulting in feelings of anxiety, panic and frustration, which were potentially 
exacerbated when coupled with common symptoms of neurodegenerative 
conditions (e.g. slowness or fatigue).  This is consistent with studies where 
participants felt rushed (Foran et al., 2016) and discomfort at being timed 
(Bennett-Levy et al., 1994).  Alike Owen’s (2012) study, some participants 
referenced the similarity of testing to formal examinations at school, perhaps 
highlighting participants felt unpractised and not in control.  In addition, 
participants described testing as a lengthy process, but did not explicitly state it 
was tiring or too long as in previous studies (Bennett-Levy et al., 1994; Conniff, 
2008; Owen, 2012).  This perhaps reflected the flexible approach adopted by the 
service recruited from, where testing was often split across numerous sessions, 
hence participants were more likely to experience the testing as lengthy rather 
than tiring.  Participants in the current study expressed their appreciation for 
splitting testing sessions and studies suggest it may improve patient satisfaction 
(Bennett-Levy et al., 1994). 
 
4.4. Consideration of Findings in Relation to Previous Literature 
 
The findings confirmed that the experience of neuropsychological assessment as 
viewed by people with neurodegenerative conditions, was largely consistent with 
previous literature that looked at various clinical populations.  For instance, 
previous studies similarly concluded assessment was mostly experienced as 
positive (Bennett-Levy et al., 1994; Donofrio et al., 1999; Longley, Tate & Brown, 
2012; Mountjoy et al., 2017; Westervelt et al., 2007), despite the testing being 
experienced as tiring, frustrating and long (Bennett-Levy et al., 1994; Conniff, 
2008; Owen, 2012; Westervelt et al., 2007).  Likewise, numerous studies also 
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highlighted the importance of the relationship with the clinician (Blake, 2004; 
Foran et al., 2016; Owen, 2012), the test environment (Bennett-Levy et al., 1994; 
Foran et al., 2016; Keady & Gilliard, 2002; Owen, 2012; Westervelt et al., 2007), 
and the value of written feedback and coping strategies (Bennett-Levy et al., 
1994; Blake, 2004; Donofrio et al., 1999) to improve quality of life and support 
acceptance (Rosado et al., 2017). 
 
Although this study has not set out to draw comparisons between groups, it is 
worth highlighting a few notable differences from the previous literature, which 
may therefore, be specific to people with neurodegenerative conditions.  For 
instance, participants spoke about weighing up a desperate desire to measure 
potential progression of their condition, whilst simultaneously fearing a negative 
outcome.  Additionally, whilst Keady and Gilliard (2002) noted participants took a 
self-evaluative stance; unlike previous studies, participants in the current study 
described an acute awareness of their perceived performance throughout testing, 
in particular a strong sense of self-doubt.  This appeared linked to the fact that 
the test may provide proof of their ‘sanity’ or progression of their illness, and 
appeared to exacerbate the experienced intensity.  Yet strikingly, it appeared that 
regardless of outcome, number of assessment or stage of disease, participants 
reported benefiting if they gained either a sense of reassurance in relation to 
retained abilities, or strategies for coping with, accepting and communicating 
difficulties to others. 
 
4.5. Clinical Implications and Recommendations 
 
4.5.1. Introduction and Preparation for Neuropsychological Assessment 
The importance of pre-assessment preparation, including wanting to be provided 
with detailed and ongoing explanation about the nature and process of 
assessment, was highlighted by this study, with participants reporting various 
views regarding their expectations of assessment.  Ideally, a pre-assessment 
meeting would allow exploration of the client’s beliefs, relationship to help and 
understanding of the referral, utilising systemic questioning, such as ‘whose idea 
was it for you to come and see us?’, ‘what do you think that person was hoping 
for?’, and ‘what were you hoping for?’ (Reder & Fredman, 1996).  As well as 
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exploring their views of the problem and concerns about the process, this style of 
questioning can reduce power imbalances, encouraging a collaborative 
approach, promoting engagement and building therapeutic rapport.  In addition, 
prior to meeting, it may be beneficial to contact the referrer to map the network 
(as numerous professionals can often be involved), considering ‘who is asking for 
what from whom?’, and ascertaining who may be a useful resource in terms of 
supporting the client to implement recommendations. 
 
If time constraints in the NHS context prevent a pre-assessment meeting, 
patients should be sent preparatory information in advance of the assessment, 
which could be in the form of a letter, leaflet or link to an online video.  This 
should outline the purpose of the assessment, what it entails, the approximate 
length, the location and clinician that will conduct the assessment, common 
reactions, and finally details regarding how and when feedback will be received, 
how the results will be used and who they will be communicated to.  It may also 
be beneficial to educate referrers to provide better information to potential clients, 
as this can provide more realistic expectations of what can be achieved through 
assessment, reducing disappointment, and significantly impacting attendance 
rates and overall satisfaction (Bennett-Levy et al., 1994; Webster; 1992). 
 
One additional consideration, is that participants described a range of emotional 
reactions in response to assessment, suggesting clinicians should not only fully 
explain the process, but should prepare clients for the emotional experience.  
Especially important, as many participants reported not undergoing formal 
examination since childhood, and with the consequence of ‘failing’ confirming 
cognitive difficulties, increasing the sense of threat.  To normalise emotional 
reactions, clinicians should discuss the potential for the assessment to be 
experienced as emotionally intense, allowing the person and clinician to identify 
helpful ways to manage this, hopefully enabling a sense of control, and 
encouraging clients to seek support if necessary.  It may be helpful to point out 
most clients receive an outcome they feel is beneficial, however it may be 
worthwhile considering how the person may feel if they do not receive their 
desired outcome, facilitating truly informed consent. 
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Given that neuropsychological assessment is a lengthy, resource heavy and 
emotionally intensive experience, it is paramount clinicians ensure people are not 
unnecessarily assessed, and that clients themselves express an independent 
desire for testing.  It may be helpful for clinicians to regularly review the decision-
making process to offer neuropsychological assessment and the outcomes of 
those assessments, to consider whether current practice best meets client’s 
needs, or whether there are other ways to reach satisfactory outcomes without 
the person needing to undergo a full neuropsychological assessment, which may 
benefit clients and promote effective use of clinical resources.  However, of note 
from an ethical standpoint is that all participants, regardless of the outcome or 
stage of disease, reported benefit from either confirmation of their abilities or 
strategies to help them cope with and accept impairment.  Therefore, it would 
only be ethical not to offer assessment if it was probable that neither of these 
outcomes would be achieved. 
 
4.5.2. Relationship with Clinician 
The therapeutic relationship between the client and clinician, emerged as an 
important factor in the assessment experience, with participants valuing a 
collaborative approach, in which they felt respected, listened to, and put at ease 
with an empathetic, open and honest approach.  Furthermore, it appears clients 
prefer being assessed by a familiar clinician, who they have met at least once 
before.  Where this is not possible, clinicians should always aim to build rapport 
prior to testing, to reduce anxiety and increase comfort.  In addition, whilst 
participants appreciated the expertise of the clinician, which is at times required, 
to reduce potential power imbalances it may be beneficial to adopt the position of 
‘expert non-expert’ (Harper & Spellman, 1994), especially during the pre-
assessment and feedback phases, where the clinician can complement clients on 
their skills, whilst acknowledging the need for assessment and coping strategies. 
 
As highlighted in the study, not receiving feedback during testing increased 
participant’s uncertainty about their performance, emphasising the need to 
balance maintaining a warm and empathetic approach whilst maintaining 
standard administration.  In light of this, it could be recommended that test 
manuals incorporate standardised strengths-focused responses during testing 
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administration (e.g. ‘you are working hard’), that externalise the problem (White, 
2007) and provide reassurance (e.g. ‘the tests are designed so everyone fails at 
some point’), particularly for anxious clients for whom the experience of ‘failure’ is 
likely to have a significant impact on self-confidence (Bennett-Levy et al., 1994).  
As Shapiro (1951) notes, clinicians who randomly distribute praise (not just 
following correct responses) are no more revealing answers than if they remained 
silent throughout, and this can only serve to improve the experience for clients. 
 
This highlights that although tests themselves are standardised, the way they are 
applied can greatly alter the experience, and requires great skill on behalf of the 
clinician.  With that in mind, the findings have implications for clinical psychology 
training, as inexperienced clinicians tend to focus on the ‘technical’ aspects of 
neuropsychological assessment (e.g. the selection, administration and 
interpretation of tests), as does the literature (Lezak et al., 2012).  It may be 
beneficial for newer clinicians to be aware of the qualitative aspects of the 
process to maximise therapeutic opportunities, and for training institutions to 
consider how best to support trainees in this endeavour, not presenting the 
discipline of neuropsychology as separate from the core skills of clinical 
psychology. 
 
4.5.3. Conducting Neuropsychological Assessment 
Optimal assessment conditions should be prioritised, following reports of 
inadequate assessment environments, especially environmental distractions 
impacting the experience of testing and participants ability to ‘perform’.  Despite 
possible limits to resources, clinicians should ensure the environment is as 
appropriate as possible; with limited distractions, adequate space, comfortable 
furnishings and suitable lighting and temperature.  This can be increasingly 
challenging for assessments conducted in patient’s homes, hence it can be 
beneficial for clinicians to be familiar with the home set up prior to testing, and to 
pre-empt and minimise potential distractors (e.g. silencing mobile phones, facing 
client away from windows, and planning the absence of other household 
occupants).  As supported by Bennett-Levy’s et al. (1994) findings, testing 
sessions should be flexible, with opportunities for split sessions and rest breaks.  
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4.5.4. Feedback and Coping Strategies 
In view of the study highlighting difficulties with delayed and inaccessible 
feedback, and a lack of coping strategies, it is clear clinicians could improve 
provision of comprehensible and meaningful feedback, especially as it has the 
potential to improve patient’s quality of life and ability to cope (Rosado et al., 
2017).  No official guidance exists for feedback of neuropsychological 
assessment, however as mentioned earlier, Gass and Brown (1992) recommend 
provision of feedback in a six-stepped approach, focussing on relative strengths 
and weaknesses, the meaning of results for daily life, and recommendations of 
coping strategies to adapt to problem areas, which should match the nature and 
stage of the condition (Moos & Schafer, 1984).  The focus on areas of strength, 
as well as coping strategies, may be particularly therapeutic for patients 
diagnosed with neurodegenerative conditions, who may underestimate their 
cognitive ability, and therefore will likely derive emotional benefit from the 
objective confirmation of ability (Gass & Brown, 1992). 
 
As emphasised in the current study, feedback regarding performance should be 
considered essential and provided directly by the clinician, in-person, in an 
understandable (providing psycho-education if necessary), collaborative, 
sensitive but direct and timely manner, allowing sufficient time for clients to 
digest, discuss implications and develop mutually agreed coping strategies and 
treatment plans (Foran et al., 2016; Westervelt et al., 2007).  Feedback could be 
provided across multiple sessions if necessary, which may enhance adherence to 
recommendations and reduce risk of misunderstandings (Brenner, 2003; Lopez, 
Roberts, Tchanturia & Treasure, 2008).  This should be swiftly followed by a 
written summary of the assessment findings and recommendations, particularly 
beneficial for cognitively-impaired populations who may be empowered by short 
simple summaries of complex information to aid recollection (Fallows & 
Hilsabeck, 2013; Gass & Brown, 1992; Smith et al., 2007).  The client must be 
involved in deciding who receives assessment results, with the opportunity to 
invite members of their system to the feedback session if desired.  This can be 
beneficial, particularly if the client is anxious about the results, which can interfere 
with them absorbing and recalling information relayed by the professional (Ley, 
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1988), hence family members can act as ‘collaborators’ in the feedback process, 
increasing client’s ongoing understanding (Postal & Armstrong, 2013). 
 
4.6. Methodological Considerations 
 
This section provides a critique of methodological issues within the current study, 
evaluating it in line with recommended procedures for the critical appraisal of 
qualitative research and highlighting its limitations. 
 
4.6.1. Demonstrating Validity and Quality in Qualitative Research 
The typical standards used to assess quantitative approaches risk being overly 
simplistic or prescriptive for effectively assessing qualitative research (Smith et 
al., 2009).  Instead, the quality of qualitative research is judged by its 
thoroughness, trustworthiness and meaningfulness, and Yardley (2000) proposes 
numerous broad ranging criteria that can be applied regardless of theoretical 
orientation.  I have strived to meet these principles throughout the research 
process and will now briefly outline and demonstrate each in relation to the 
current study. 
 
4.6.1.1. Sensitivity to context: This can occur in various ways throughout the 
research process, and includes sensitivity to participant’s perspectives, the data 
collected, and the sociocultural context of the research (Yardley, 2017).  The 
current study demonstrated sensitivity to context, firstly by presenting an 
awareness of existing literature, both on the topic and method used.  Secondly, 
great care and skill was taken designing and implementing the study, for instance 
conducting interviews in an empathetic manner, whilst negotiating and adjusting 
the interview style for possible cognitive difficulties and attempting to reduce 
power differentials to encourage participant’s free expression.  Thirdly, sensitivity 
to data was achieved during the immersive analytic process and displayed in 
both the audit trail (see Appendix K) and throughout the narrative account by 
grounding possible interpretations using a substantial number of extracts from 
participants, ensuring claims were not pre-conceived, but cautious and 
appropriate to the sample (Smith et al., 2009).  Finally, the reflective journal and 
subsequent personal reflections presented in this chapter, allowed me to consider 
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how the wider context influenced my own beliefs and assumptions and that of 
participants. 
 
4.6.1.2. Commitment and rigour: Yardley (2017) states that commitment and 
rigour can be demonstrated through “in-depth engagement with the topic, 
including thorough data collection, displaying expertise and skills in the methods 
employed, and undertaking a detailed, in-depth analysis” (p.295-296).  To ensure 
commitment in the current study, I was dedicated to developing competence in 
core research skills, reading the IPA literature extensively and attending 
workshops on the subject.  I was aware that researcher’s analysis often becomes 
deeper and richer as they gain experience (Smith, 2011), so as novice qualitative 
researcher, I was determined to counteract this as much as possible.  Practicing 
the interview technique allowed me to actively listen and pay close attention to 
participants accounts during data collection, and personally transcribing and re-
reading all interviews allowed me to become immersed in the data.  Throughout 
the entire process, from planning to analysis of results, I met regularly with my 
research supervisor to seek guidance on the process. 
 
To ensure rigour, the sample was carefully selected to be relatively homogenous 
(as favoured in IPA; Smith et al., 2009) and the interview schedule was used 
flexibly, allowing me to follow up on important cues, resulting in the emergence of 
rich data.  The analysis adhered to the framework suggested by Smith et al., 
(2009), conducting extended exploration of the data, and endeavoured to be 
sufficiently interpretative, grounding interpretations in substantial quotes that 
evenly represented each participant.  The research supervisor, experienced in 
supervising IPA, independently reviewed sections of my analysis, resulting in 
broadly similar themes, and highlighting possible modifications to refine and add 
richness to my analysis, whilst respecting the double hermeneutic process.  This 
was an attempt to mutually confirm consistency of themes (Knafl & Breitmayer, 
1991) and employ contextualist triangulation, which aims to enhance 
completeness, but not necessarily objectiveness (Madill, Jordan & Shirley, 2000).  
Furthermore, respondent validation was considered to further determine the 
credibility or ‘fit’ of themes, but was decided against on several bases, including 
that it would place unremunerated demands on participants (both emotionally and 
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time-wise) and would raise ethical dilemmas in considering how much to alter 
analysis based on individual concerns (Barbour, 2001; Mays & Pope, 2000). 
 
4.6.1.3. Transparency and coherence: “Transparency means the reader should 
be able to see clearly how the interpretation was derived from the data” (Yardley, 
2017, p.296).  Hence in the current study, the data collection and analytic process 
have been described in detail, themes clearly evidenced with quotes, and an 
audit trail and a worked example of a transcript included (see Appendix J and K).  
Coherence refers to the clarity of the constructed argument and examines the 
appropriateness of the underlying epistemology, method and analysis to respond 
to the research question (Yardley, 2000).  To ensure coherence in the current 
study, numerous drafts were completed and the methodological approach chosen 
was considered the best fit with the epistemological position of critical realism 
and the study’s aims of exploring individual’s experience. 
 
4.6.1.4. Impact and importance: Yardley (2000) argues the ultimate value of 
research is whether it generates knowledge considered important or useful, that 
has a theoretically, clinically or socio-culturally impact on how we view the world.  
The current study aimed to increase understanding of the experience of 
neuropsychological assessment, specifically from the viewpoint of people with 
neurodegenerative conditions, allowing participants to feel valued and hopefully 
resulting in recommendations to guide clinicians, further refining and improving 
clinical practice.  It is hoped the focus and novel design of the study will add 
enormous value to the paucity of literature in this area. 
 
4.6.2. Limitations 
4.6.2.1. Recruitment: Recruiting participants proved problematic, and I reflected 
this may be one reason this group’s voices are not heard.  This led to an early 
revision of inclusion criteria resulting in removal of the upper age limit.  
Furthermore, as potential participants were identified by clinicians, there is a 
possibility of bias in participant selection.  For instance, as the study focuses on 
participant’s experience, some clinicians may have felt concerned their 
therapeutic skills were being evaluated, causing them to be reluctant to suggest 
potential participants, or selecting those they perceived as having a positive 
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experience.  Additionally, for neuropsychological assessments that took place 
whilst the study was actively recruiting, clinicians would have been aware the 
person may take part in the study, hence they may have acted differently (e.g. 
providing clearer explanations, showing increased empathy).  Lastly, as 
participation was voluntary, those who agreed to take part likely did so out of 
interest for the topic or because they had something they wanted to share 
(positive or negative), potentially skewing the sample as the study was unable to 
capture views of those who declined to take part. 
 
4.6.2.2. Homogeneity of sample: As noted earlier, IPA recommends a relatively 
homogenous sample in the sense that participants have experienced a similar life 
event, in this case a neuropsychological assessment to assess potential cognitive 
deterioration caused by a neurodegenerative condition.  It could be argued the 
current sample lacked homogeneity in terms of demographic and clinical 
characteristics (e.g. age, gender, diagnosis, length of diagnosis, the clinician, the 
time since and outcome of the assessment), and these differences may have 
coloured the experiences reported in participants accounts.  For instance, studies 
suggest people report increased satisfaction with healthcare if they are older 
(Hordacre, Taylor, Pirone & Adams, 2005) and if their experience was more 
recent (Mountjoy et al., 2017).   
 
Furthermore, differences between various neurodegenerative conditions, 
including specific disadvantages and varying trajectories, such as the tremor 
specific to PD, the unpredictable course of MS, the hereditary properties of HD or 
the rapid and fatal progression of MND and MSA, may have influenced how the 
assessment was perceived and whether it felt more or less helpful.  Likewise, 
with age and sex differences across diagnoses, for instance PD affecting more 
males and MS more likely to affect younger females, there is added variation 
between the different conditions contained within the sample. However, to 
remove all differences between participants is neither pragmatic or necessary, 
hence it was felt the similarity in life events that participants shared was sufficient 
for analysis of the phenomenon. 
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4.6.2.3. Generalisability: It is recognised that as an idiographic approach, IPA is 
limited in terms of generalisability of findings (Smith et al., 2009), instead 
emphasising in-depth accounts of a few individuals, with the aim of contributing to 
a gradually developing knowledge base (Smith & Osborn, 2007).  An example of 
the limited generalisability in the current study, was that participants were white 
European, hence their accounts may not reflect experiences of people from other 
ethnicities and cultures, who may report different experiences, especially as 
neuropsychological tests, at least in part, represent culturally learned ability 
(Ardila, 1995) and may not be performed in the person’s native language.  
Similarly, all participants were recruited from a single service, hence their 
described experience may be influenced by other therapies received at the 
service or processes specific to that department.  Therefore, participant’s account 
may not reflect experiences across other neuropsychology services, although it is 
worth cautiously noting that practices are likely to be similar to those used in 
other neuropsychology services across the UK.  Whilst both examples ensure, to 
some degree, that accounts are obtained from participants with a shared 
experience (in keeping with IPA principles; Smith & Osborn, 2003), it is important 
to balance this with the need to expand and replicate the current study in other 
populations, to broaden claims that can be made from the findings. 
 
With the concept of generalisability stemming from a positivist epistemology, it 
may be more beneficial to instead consider transferability, which places 
responsibility on the reader to cautiously make connections between their own 
experience and the study (Trochim, 2006).  In this sense, it is possible for study 
findings to “give rise to explanations which potentially apply to new cases” (Willig, 
2001, p.82).  In considering the literature, there are limited studies with which to 
compare, yet findings from this study appeared consistent with previous findings 
in other populations, and I am confident my interpretations have captured 
experience that is likely to be shared by other people with a neurodegenerative 
condition who undergo a neuropsychological assessment. 
 
4.6.2.4. Interviews: Qualitative interviews have been critiqued for being potentially 
artificial and misleading (Potter & Hepburn, 2005), for instance social desirability 
bias may cause participants to respond to questions in a certain way to be 
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viewed favourably.  Despite being fully briefed on anonymity, participants may 
have felt reluctant to express dissatisfaction, assuming I was directly employed 
by the service, hence I ensured to explicitly highlight my relationship with the 
service.  On reflection, I considered how prompts during the interviews acted to 
reinforce participant’s answers, steering conversation and ultimately impacting 
the themes generated.  To avoid overly pursuing certain responses or topic areas, 
I was mindful of my body language, prompts and potentially leading questions, 
always finishing interviews offering participants to opportunity to tell me anything 
not covered in the interview. 
 
4.7. Personal Reflections 
 
As a researcher new to qualitative interviews, I was apprehensive about 
transitioning from the role of therapist to researcher, and mindful to clearly 
introduce my role at the beginning of interviews, ensuring I tailored questions 
towards the research focus.  Occasionally, I would notice a tendency to ‘slip back’ 
into a therapeutic role, especially if participants asked me a direct question 
regarding their assessment, although I was able to notice this more rapidly as I 
became more experienced, instead advising participants to contact a professional 
at the service.  Concerned about not achieving a ‘rich’ interview, I reminded 
myself prior to meeting participants to maintain a slow pace, ask questions 
infrequently and allow participants time to fully answer questions (Smith et al., 
2009).  However, due to a mixture of participant’s cognitive difficulties and my 
reluctance to interrupt, the first interview was considerably longer than expected, 
yet failing to interrupt meant the participant fatigued as we began to revisit earlier 
topics at a deeper level.  Following discussion in supervision, I felt increased 
confidence to balance ‘not jumping in too quickly’, with a need to move 
conversation on from less relevant topics to achieve the best out of the 
participant within the time frame.  This caused me to reflect upon the amount of 
power held by researchers during interviews (e.g. deciding what to ask, what to 
follow up and when to finish the interview) (Kvale, 2006), which I found ironic 
considering the aim of the research to empower participants.  Whilst impossible 
to entirely remove the inherent power imbalance (Yardley, 2000), I made 
considerable efforts to reduce its influence, such as constantly ‘checking in’ with 
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participants and reassuring them I was interested to hear their views as experts 
by experience. 
 
As some degree of self-disclosure is unavoidable conducting interviews, I 
wondered how my age, sex, ethnicity, appearance and status as a clinical 
psychology doctoral student influenced participant’s responses, and whether this 
encouraged or inhibited participants from sharing certain elements of their 
experience.  Furthermore, as someone who had neither experienced a 
neurodegenerative condition or neuropsychological assessment (from a patient’s 
perspective), I speculated whether participants may assume my view would be in 
line with the dominant socio-cultural narratives of illness, including ideas of 
stigma around cognitive decline (Krendl & Wolford, 2013), burden (Johnson, 
Sulmasy & Nolan, 2007) and metaphors of being a ‘fighter’ (Coulehan, 2009) and 
how this might have played out in their accounts (e.g. was neuropsychological 
assessment or taking part in the research a way to ‘give back’ and show they 
were fighting?).  In considering my own epistemological stance, I noticed at times 
I became influenced by realist ideas about representing ‘true’ experience, 
although undoubtedly it was the ‘critical’ aspect of critical realism that largely 
influenced the research process, including my interpretations. 
 
4.8. Future Research 
 
Given that studies focused on a neglected area, there are myriad opportunities 
for future research.  This study has highlighted the value of qualitative 
approaches, hopefully illustrating and encouraging further qualitative research to 
enhance the understanding of people’s lived experience.  To gradually build a 
picture of larger populations (Smith et al., 2009), this study could be extended to 
diverse groups that undergo neuropsychological assessment, for instance 
including people from various cultures and services, and people suffering with 
various conditions (e.g. stroke, epilepsy, hydrocephalus and encephalitis).  It 
would also be worthwhile conducting further studies focusing specifically on 
separate neurodegenerative conditions, to achieve greater sample homogeneity 
and to explore in detail the experience of people with distinct conditions.  As each 
condition is associated with unique patterns of cognitive change and variable 
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trajectories, it follows that each group, indeed each person, will have unique 
elements to their experience worthy of consideration, to inform improvements in 
clinical practice. 
 
Furthermore, considering the multitude of factors that can influence an 
individual’s experience, it would be interesting to conduct comparative studies 
looking at whether the experience of neuropsychological assessment differs 
depending on the outcome, the client’s pre-morbid ability and the stage of 
disease progression.  This would build on or disprove the hypothesis that people 
are more likely to report negative experiences of assessment as their disease 
progresses and performance deteriorates, compared to those in the early stages, 
and would raise ethical dilemmas as to who should be offered neuropsychological 
assessment. 
 
In terms of the study’s design, IPA provided a preliminary exploration into 
people’s experience without attempting to explain the experience.  I reflected that 
grounded theory, with its focus on generating theoretical explanations (Starks & 
Brown Trinidad, 2007), could go on to explain ‘what factors influence how people 
manage neuropsychological assessment?’.  Alternatively, I wondered whether 
discourse analysis, with its emphasis on understanding how people use 
language, would have allowed a closer inspection and understanding as to the 
psychological, medical, social and cultural discourses participants used to 
describe their experiences and how this impacted on the meaning they attributed 
to being assessed (Starks & Brown Trinidad, 2007).  Alternatively, in a bid to 
achieve a multi-layered or well-rounded understanding and avoid limitations of 
any single method, it may be desirable to employ triangulation of the data, using 
numerous methods (e.g. interviews, observations) from various sources (e.g. 
patient, clinician, relative) (Yardley, 2000). 
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Appendix H: Participant Record Form
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Appendix I: Simple Transcription Scheme (Adapted from Bannister et al., 2011) 
 
(.) One second pause 
(..) Two second pause 
(…) Three second pause 
(4) For pauses longer than four seconds  
= No gap between speakers 
/ Denotes people speaking at the same time 
:::: Lengthening of a sound 
tr-trail off Person trails off or doesn’t finish a word 
emphasis Words spoken with more emphasis that others 
LOUD Loud sounds 
(.hhh) Audible in-breath 
(Hhhhh) Audible out-breath 
[sounds/action] Sounds of actions during interview e.g. [both laugh] 
[inaudible] Inaudible section of transcript 
[identifiable 
information] 
Any information that may identify a participant e.g. a person’s 
name, a location 
I: Denotes the interviewer 
 
To protect participant’s confidentiality, pseudonyms were assigned and used in the 
transcripts and quoted in the thesis alongside line numbers e.g. (John, 124) 
(pseudonym, line number). 
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Appendix J: Worked Example of Transcript 
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Appendix K: Audit Trail of Themes  
 
Initial Phase 
 
 
Super/subordinate Themes 
 
 
Elements of Themes 
Hopes / expectations of the process 
 
 
 
 
 
Anticipating possible outcomes 
Hopes / expectations of the process 
Seeking knowledge and empowerment 
To measure progression 
Objectivity of assessment 
Uncertainty 
Expectation ‘should’ do assessment 
Anticipating possible outcomes 
Confirmation of cognitive decline 
Communication style 
 
 
 
 
 
 
 
 
 
Familiarity  
 
Expertise 
 
Communication style 
Conscientious 
Collaborative 
Respectful 
Put people at ease 
Good communication 
Empathy allows vulnerability 
Openness 
Unheard, misunderstood 
Hesitancy to break bad news 
Familiarity  
Familiarity builds trust  
Expertise 
Expertise 
Opinion held weight 
Positive aspects 
 
Mixed aspects 
 
Negative aspects 
 
 
 
 
 
Environment 
 
 
Awareness of performance 
 
 
 
 
 
Positive aspects 
Pleasant 
Mixed aspects 
Unusual 
Negative aspects 
Time pressure 
Intensity 
Requires concentration 
Lengthy, repetitive 
Interrogated re education 
Environment 
Comfortable 
Distractors problematic 
Awareness of performance 
Retained ability 
Exposing lost ability 
Failures salient as confirming problem 
Performance relative (to self and others) 
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Response to testing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Power and control 
Response to testing 
- Emotional 
Curiosity 
Confident, resilient 
Stressful, frustrated 
Self doubt 
Self punishing 
- Thought Process 
Meta thinking process simultaneously 
occurring 
Questioning reason for perceived poor 
performance 
- Coping 
Attempt to identify strategies 
Protect self from failure 
Defence mechanisms 
Power and control 
Empowered if fully briefed  
Passive recipient 
Positive outcomes 
 
 
 
 
 
 
Negative outcomes 
 
Time sensitive 
 
 
Emotional impact 
 
 
 
 
 
Coping strategies provide power and 
control 
 
 
 
 
 
 
Family 
 
 
 
 
Positive outcomes 
Understandable 
Reconfirmation of retained self identity 
Reassurance no fundamental problems 
Proof of own sanity 
Proof not lazy 
Externalised burden 
Negative outcomes 
Report technical 
Time sensitive 
Frustration at unexplained delay 
exacerbated by limited life expectancy 
Emotional impact 
Therapeutic 
Reconnection to hope 
Frustrated / scared re lost ability 
Low mood / grieving loss 
Mixed / changeable 
Coping strategies provide power and 
control 
Facilitated coping 
Gained strategies to compensate 
Lack of strategies disappointing 
Ability to understand provided power 
Knowledge empowering 
Allowed adjustment and acceptance 
Family 
Increasing family’s insight 
Seeking family’s care 
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Future 
 
 
 
Implications 
 
 
Future 
Preparation for future 
Continued uncertainty re future 
progression 
Implications 
Increased self-doubt over work 
performance 
Loss of roles 
Permission giving to change role 
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Middle Phase 
 
 
Superordinate Themes 
 
 
Subordinate Themes 
 
Elements of Themes 
Expectations of 
assessment 
To measure cognitive 
decline 
 
 
Anticipating 
understanding and 
coping advice 
 
 
 
 
Pressures and fears 
 
To find and confirm 
‘hidden’ cognitive decline 
To measure progression 
 
Seeking understanding 
and coping 
Seeking knowledge / 
understanding / 
explanation 
Advice on coping 
 
Anticipating possible 
outcomes  
Expectation ‘should’ do 
assessment 
Relationship with 
clinician 
 
Positive clinician 
qualities 
 
 
 
 
 
 
Clinician supported 
coping 
 
 
 
 
 
Familiarity and trust 
 
Expertise and power 
Communication style 
Conscientious 
Collaborative 
Respectful 
Good communication 
Openness 
Unheard, misunderstood 
 
Helped coping 
Put people at ease 
Empathy allows 
vulnerability 
Hesitancy to break bad 
news 
 
Familiarity builds trust  
 
Expertise 
Opinion held weight 
Experience during 
testing 
 
Awareness of 
performance 
 
 
 
 
 
 
 
 
Grateful for retained 
ability 
Exposing lost ability 
Failures salient as 
confirming problem 
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Psychological response 
to testing 
 
 
 
 
 
 
 
 
 
 
 
Coping with testing 
 
 
 
 
 
 
Intense and prolonged 
 
 
 
 
 
 
 
Importance of 
environment 
- Thought Process 
Meta thinking process 
simultaneously occurring 
Questioning reason for 
perceived poor 
performance 
- Emotional 
Curiosity 
Confident, resilient 
Stressful, frustrated 
Self doubt 
Self punishing 
 
- Coping 
Resilience (attempt to 
identify strategies 
Denial (protect self from 
failure / defence 
mechanisms) 
 
Time pressure 
Intensity 
Requires concentration 
Lengthy, repetitive 
Interrogated re education 
Passive recipient 
Similarity to school 
 
Comfortable 
Distractors problematic 
Outcome of assessment 
 
Communication of 
results 
 
 
 
 
 
 
 
Understanding of 
results 
 
 
 
 
 
 
 
 
 
Empowered if fully briefed  
Negative outcomes 
Report technical 
Time sensitive 
Frustration at unexplained 
delay exacerbated by 
limited life expectancy 
Family: Involvement 
 
Positive outcomes 
Understandable 
Reconfirmation of 
retained self identity 
Reassurance no 
fundamental problems 
Proof of own sanity 
Proof not lazy 
Proof not mad 
Externalised burden 
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Emotional impact 
 
 
 
 
 
 
 
 
 
 
Coping strategies 
provided power and 
control 
 
 
 
 
 
 
 
 
Future implications 
 
 
 
 
 
 
 
 
 
Objectivity of 
assessment 
Family: Increasing 
family’s insight 
Seeking family’s care 
 
Therapeutic 
Reconnection to hope 
Frustrated / scared re lost 
ability 
Low mood / grieving loss 
Mixed / changeable 
Family: Shared relief 
Reality breaks defences 
Feel during, process 
after 
 
Facilitated coping 
Gained strategies to 
compensate 
Lack of strategies 
disappointing 
Ability to understand 
provided power 
Knowledge empowering 
Allowed adjustment and 
acceptance 
 
Preparation for future 
Continued uncertainty re 
future progression 
(concern re future 
madness) 
Increased self-doubt over 
work performance 
Loss of roles 
Permission giving to 
change role 
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Final Stage 
 
 
Superordinate Themes 
 
 
Subordinate Themes 
Expectations of assessment 
 
Deciding to undergo assessment 
To measure cognitive decline 
Anticipating understanding and coping 
advice 
Relationship with clinician 
 
Positive clinician qualities supported coping 
Familiarity and trust 
Expertise and power 
Experience during testing 
 
Subjective awareness of performance 
Emotional response to testing 
Coping with testing 
Intense and prolonged 
Importance of environment 
Outcome of assessment 
 
Communication of results 
Meaning of results 
Emotional impact of results 
Coping strategies provided power and 
control 
Future implications 
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Appendix L: Matrix Identifying Recurrence of Themes Within Participant’s Accounts 
 
 Helen Stephen Sheila Jean Graham Wendy Lisa Arthur Total 
 
Expectations of assessment 
         
Deciding to undergo assessment         6 
To measure cognitive decline         7 
Anticipating understanding and coping advice         7 
 
 
         
Relationship with clinician          
Positive clinician qualities supported coping         7 
Familiarity and trust         4 
Expertise and power         4 
 
 
         
Experience during testing          
Subjective awareness of performance         8 
Emotional response to testing         7 
Coping with testing         6 
Intense and prolonged         6 
Importance of environment         4 
 
 
         
Outcome of assessment          
Communication of results         7 
Meaning of results         5 
Emotional impact of results         5 
Coping strategies provided power and control         7 
Future implications 
 
        3 
 
